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Résumé 
  
 Mon cursus scientifique a débuté avec mes études universitaires en Biochimie à 
l’Université de Cambridge en Angleterre, suivies de ma thèse effectuée au sein du laboratoire 
de Winfried Weissenhorn à l’EMBL et de mon travail de post doctorante puis de scientifique 
à l’ESRF dans le groupe de Biologie Structurale dirigée par Sean McSweeney. Ces travaux 
m’ont mené jusqu'à l’Institut de Biologie Structurale (IBS) que j’ai rejoins en 2011 avec 
l’aide d’une bourse ATIP-AVENIR pour y monter ma propre équipe. Durant ces années, j’ai 
eu l’occasion d’encadrer un grand nombre d’étudiants pour des périodes variant de quelques 
semaines (dans le cas de stagiaires) à quelques années (dans le cas de thésards), mais aussi de 
publier de nombreux articles dans des revues à comité de lecture.  
 En rejoignant l’ESRF en 2003 pour participer à un projet européen (FP6 ; EURAMAN) sur 
l’étude des protéines lysosomales, je me suis rapidement impliquée dans le projet de 
génomique structurale centré autour de la bactérie Deinococcus radiodurans. Cette bactérie 
est une bactérie polyextrêmophile et l'un des organismes les plus radiorésistants connu au 
monde. Cette bactérie présente une résistance impressionnante, notamment aux UV, aux 
rayonnements ionisants, au peroxyde d'hydrogène, aux températures extrêmes, au 
dessèchement, au froid et à la famine. Cette capacité de résistance est due à sa structure 
cellulaire particulière et à son système très perfectionné de réparation de l'ADN, qui lui 
permet même de reconstituer un génome intact quelques heures à peine après avoir été 
irradiée avec des doses de rayonnement qui sont létales pour tout autre organisme sur terre. 
 Avant de détailler mes travaux dans le cadre du projet de génomique structurale et sur les 
protéines de réparation de l’ADN de D. radiodurans, je décris dans un premier temps mon 
intérêt et mon rôle dans l’étude de la résistance de cette bactérie aux rayons X. En 2006, nous 
avons en effet irradié D. radiodurans avec des doses croissantes de rayons X (expériences 
effectuées sur la ligne de lumière médicale ID17 de l’ESRF) afin de suivre le taux de survie et 
l’effet de fortes doses de rayons X sur la courbe de croissance de cette bactérie. Par ailleurs, 
j’ai également collaboré avec une équipe de chercheurs sur la ligne ID10 de l’ESRF pour le 
développement de l’imagerie par diffraction cohérente, une étude qui a permis d’obtenir une 
image reconstituée de D. radiodurans à une résolution de près de 30nm, une première sur un 
si petit échantillon biologique. 
 Le projet de génomique structurale a débuté en 2002 et s’est poursuivi jusqu’en 2006-
2007. Pendant cette période, le groupe de biologie structurale de l’ESRF a sélectionné 100 
cibles d’intérêt impliquées dans la résistance aux rayonnements, a réussi à purifier un très 
grand nombre de ces protéines et a déterminé les structures cristallines de 13 d’entre elles. Je 
décris donc mon rôle dans l’avancement et la coordination de ce projet à grande échelle.  En 
2006 je suis nommée coordinatrice du projet de recherche sur D. radiodurans. 
 Ma participation au projet de génomique structurale a débuté avec l’étude d’une enzyme, 
maltooligosyltrehalose trehalohydrolase, impliquée dans la synthèse d’un disaccharide 
nommé trehalose jouant un rôle essentiel dans la protection des cellules contre le stress 
oxydatif. Pour ce projet, j’ai obtenu des cristaux de la protéine intacte et j’ai déterminé sa 
structure cristalline par la méthode SAD (single wavelength anomalous dispersion) à partir de 
cristaux de protéine séléniée. Par la suite nous avons déterminé sa structure en complexe avec 
du sucrose, d’une part et avec du trehalose, d’autre part. Ceci nous a permis d’identifier les 
résidus catalytiques, le mécanisme permettant la discrimination entre le trehalose et le sucrose 
et les sites d’interaction avec ces sucres. Ce projet m’a permis de découvrir les différentes 
techniques utilisées en cristallographie des protéines. 
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 Peu après, j’ai travaillé aux côtés d’Ingar Leiros sur l’étude de la protéine RecO de D. 
radiodurans, une protéine impliquée dans la réparation des cassures double brin de l’ADN. 
Nous avons déterminé sa structure cristalline, puis étudié sa capacité à interagir avec l’ADN. 
Nous avons préparé de nombreux mutants afin d’identifier les régions de RecO impliquées 
dans cette interaction avec l’ADN. Ce premier projet nous a mené à l’étude de l’interaction de 
RecO avec RecR, une protéine formant un tétramère en forme d’anneau. Très rapidement 
nous avons obtenu des cristaux de ce complexe, mais ceux-ci ne diffractaient les rayons X que 
faiblement. Nous avons tout de même réussi à mesurer un jeu de données à une résolution 
maximale de 3.8 Å et la structure du complexe fut résolue par remplacement moléculaire. Le 
complexe est formé d’un tétramère de RecR avec une molécule de RecO de part et d’autres de 
l’anneau de RecR, formant ainsi un hétérohexamère. Là aussi, nous avons préparé de 
nombreux mutants pour confirmer l’importance des interactions protéines-protéines observées 
dans notre structure et également pour identifier les résidus de RecO et RecR impliquées dans 
la reconnaissance de cassures double-brin dans le contexte du complexe. Ces travaux ont 
ensuite été poursuivis de 2008 à 2011 par un post-doctorant, Jens Radzimanowski, qui a 
réussi à obtenir une nouvelle forme cristalline de ce complexe et a pu obtenir des données à 
une résolution de 3.3 Å améliorant ainsi nettement la qualité de nos données structurales sur 
ce complexe. Par ailleurs, Jens a effectué une étude de SAXS et de SANS (Small-angle X-ray 
scattering et Small-angle neutron scattering) sur le complexe et sur RecR seule en présence ou 
non d’ADN nous révélant le mode d’interaction de RecO-RecR avec l’ADN. 
 De 2008 à 2012, j’ai encadré un étudiant en thèse, Simone Pellegrino, qui a travaillé sur la 
protéine RecN, jouant un rôle essentiel dans les premières étapes de reconnaissance de 
cassures double-brin dans l’ADN. Au départ du projet, aucune information structurale n’était 
disponible pour RecN. Simone a déterminé les structures cristallines de trois fragments de 
RecN et, avec l’aide d’une enveloppe de la protéine entière déterminée par SAXS, a pu 
reconstituée une structure quasi atomique de cette protéine très allongée (300 Å de long) 
appartenant a la famille des SMC (Structural Maintenance of Chromosomes). Simone a 
également étudié le rôle de la fixation et de l’hydrolyse de l’ATP dans l’activité et 
l’oligomérisation de RecN. 
 Dès 2005, je me suis intéressée aux protéines UvrA, UvrB, UvrC et UvrD impliquées dans 
la réparation des lésions de l’ADN induites par les rayonnements ultra-violets (UV). 
Contrairement à la majorité des bactéries, D. radiodurans, bien connue pour sa très forte 
résistance à la sècheresse, aux stress oxydants et aux rayonnements UV et ionisants, possède 
deux formes d’UvrA : UvrA1 et UvrA2. UvrA1 est présente chez tous les procaryotes et joue 
un rôle essentiel dans la reconnaissance des lésions telles que les dimères de cycobutane. Le 
rôle d’UvrA2 n’a pas encore été élucidé. Nous avons déterminé la structure cristalline 
d’UvrA2 en complexe avec de l’ADP à une résolution de 2.3 Å par la méthode MAD (multi-
wavelength anomolous dispersion) grâce à la présence de 2 atomes de zinc associés avec 
chaque monomère d’UvrA2. La structure révèle qu’UvrA2 forme un dimère et que chaque 
unité est constituée de 2 domaines de fixation de nucléotides (NBD, nucléotide binding 
domains) repliés l’un sur l’autre formant ainsi deux sites de fixation de l’ATP par monomère. 
Nos études complémentaires (interaction avec l’ADN lésé et mutagénèse) ont identifié les 
résidus et domaines impliqués dans la reconnaissance de lésions et nous ont permis de 
proposer un modèle de l’interaction d’UvrA2 avec l’ADN endommagé.  
 Plus récemment, nous avons déterminé les structures cristallines d’UvrD, une ADN 
hélicase de type SF1A (Superfamily 1A) de D. radiodurans (drUvrD) en complexe avec 
différents ADNs et nucléotides, nous offrant plusieurs vues du processus d’ouverture de la 
double hélice. Chez D. radiodurans UvrD joue un rôle essentiel dans de nombreuses voies de 
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réparation de l’ADN. Nos structures mettent en évidence des changements conformationnels 
de grandes ampleurs et améliorent notre compréhension des mécanismes moléculaires qui 
régulent les hélicases de type SF1A. A notre grande surprise, nos données biochimiques ont 
également démontré que drUvrD déroule l’ADN de 5’ vers 3’, une polarité caractéristique des 
hélicases de type SF1B et non SF1A. Cette polarité inversée est obtenue en interagissant avec 
l’ADN dans le sens opposé et souligne plusieurs différences structurales et fonctionnelles 
entre les hélicases de type SF1A et SF1B.  
 En 2005, une post-doctorante, Elin Moe, a visité l’ESRF pendant quelques mois pour 
travailler sur la détermination des structures des enzymes impliquées dans la voie de 
réparation par excision de bases chez D. radiodurans. Petit à petit, notre intérêt commun pour 
les mécanismes de réparation de l’ADN nous a rapproché et je me suis impliquée dans ce 
projet également. En 2007 nous avons obtenu un financement pour un(e) thésard(e) qui 
partagerait son temps entre l’ESRF et l’université de Tromsø en Norvège. Aili Sarre a donc 
été recrutée en 2008 pour étudier les trois Endonucléases III de D. radiodurans. Les 
endonucléases III reconnaissent les pyrimidines oxydées. Aili va soutenir sa thèse début 2013. 
Elle a déterminé les structures cristallines des Endonucléases III-1 et III-3 et a étudié leurs 
activités respectives et leurs différentes spécificités de substrats.  
 Le projet de recherche que je souhaite maintenant développer à l’IBS avec l’aide de mon 
ATIP découle logiquement de ces travaux effectués durant mes 8 années passées à l’ESRF. 
Mon équipe s’intéresse aux mécanismes moléculaires impliqués dans la reconnaissance et la 
réparation des lésions de l’ADN chez l’homme et chez D. radiodurans. Nos travaux se 
concentrent sur deux aspects qui sont : (i) La dynamique des processus de réparation de 
l’ADN et (ii) La reconnaissance des lésions dans l’ADN. L’objectif est d’utiliser une 
combinaison de méthodes de Biologie Structurale, d’outils biophysiques et biochimiques et 
de techniques d’imagerie de fluorescence sur molécules uniques afin de décrypter les 
processus moléculaires complexes menant à la réparation des lésions de l’ADN. 
 
Summary 
Deinococcus radiodurans is an unusual bacterium, displaying an outstanding resistance to 
desiccation, ionising radiation and DNA damaging agents. I became interested in this 
organism initially in the context of an ongoing structural genomics project at ESRF, which I 
joined in 2003. This structural genomics project led to the determination of a dozen crystal 
structures of proteins associated with the radiation-resistance phenotype of D. radiodurans. In 
addition, a number of complementary approaches were used to study this organism such as 
irradiation of cells on the medical beamline or coherent diffraction imaging of frozen cells. 
By 2006, I had become particularly involved in the structural and biochemical studies of 
several essential DNA repair proteins involved in homologous recombination and the 
nucleotide-excision repair pathways. A strong collaboration with NorStruct in Tromsø also 
led me into the base-excision repair field. My interest in the DNA repair mechanisms of D. 
radiodurans brought me to the IBS in 2011 with an ATIP-Avenir grant, where I am now 
establishing my own team, focusing on the early steps of DNA repair, involving the specific 
recognition of DNA damages. My objectives are to determine the principles of damage 
localisation and recognition in cells by using high- and low-resolution structural studies 
combined with super-resolution imaging of the repair machinery in cells. 
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Part I: Summary of research career 
A. Curriculum vitae 
Joanna TIMMINS  
Institut de Biologie Structurale 
Virus Infection and Cancer Group   Phone: +33 438 782 209 
41, rue Jules Horowitz    Mobile: +33 671 680 296 
38027 Grenoble Cedex 1    E-mail: Joanna.timmins@ibs.fr 
 
Married, 2 children (2 and 4 years old) 
Date of birth: 7th August 1977 
Nationalities: British/French 
 
 
Current status 
Head of the DNA Damage & Repair team at the IBS, Grenoble since May 2011. 
Research experience 
2006-2011: Scientist in the Structural Biology Group, European Synchrotron Radiation 
Facility, Grenoble, France.  
Responsibilities: Manager of the ESRF biochemical laboratory, leader of the DNA repair 
project and coordinator of the in-house Deinococcus radiodurans structural genomics project. 
Research interests: Structural Biology of key proteins and macromolecular assemblies 
involved in prokaryotic DNA repair pathways. 
2003-2006: Post-doctoral fellow in the Structural Biology Group, European Synchrotron 
Radiation Facility, Grenoble, France.  
Research projects: (i) Structural and functional studies of the human GlcNAc-
phosphotransferase enzyme, responsible for targeting of proteins to lysosomes (FP6 project; 
EURAMAN). Initial work on this project was carried out in Tromsø, Norway (one month 
visit) and the subsequent development of a large-scale overexpression system in mammalian 
cells and in vitro characterisation was achieved in Grenoble.  
 (ii) High resolution structure determination of the maltooligosyltrehalose 
trehalohydrolase enzyme from D. radiodurans in complex with disaccharides, as part of the 
ongoing structural genomics initiative in the Structural Biology Group at ESRF. 
 (iii) Structural and functional studies of key DNA repair proteins from 
D. radiodurans involved in Recombinational Repair (RecO and RecOR) and Nucleotide 
Excision Repair (UvrA2). 
Education 
1998-2003: PhD at the European Molecular Biology Laboratory, Grenoble (registered at 
the Open University, UK). Thesis supervisor: Dr W. Weissenhorn. PhD awarded on 12th 
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December 2002. Thesis title: Structural and functional studies of human ADAM12 in 
myoblast fusion and Ebola virus VP40 in assembly.  
1995-1998: B.A. degree in Natural Sciences/Biochemistry (1st class) from the University of 
Cambridge, UK.  
 
Funding 
• In 2008, I was awarded an ESRF PhD Fellowship to fund a graduate student for three years 
to work on “Structural insight into recombinational repair in Deinococcus radiodurans”. 
• Co-applicant on a research grant application to the Norwegian Research Council (project 
number: 185269/V30), entitled “Functional and structural biology studies of DNA repair 
proteins from the radiation resistant bacterium Deinococcus radiodurans”. The main proposer 
is Professor Arne Smalås, head of the Norwegian Structural Biology Centre (NorStruct) at the 
University of Tromsø in Norway. The grant was awarded in October 2007 to support a 
graduate student for 4 years. The graduate student started her work in September 2008. 
• At ESRF, my research was funded by the in-house biological research programme of ESRF 
that funds instrumentation and technological development of the protein crystallography 
beamlines as well as structural biology projects. 
• My current research is supported by an ATIP-AVENIR Grant (CNRS/INSERM) awarded to 
me in 2010 to set-up my own research team at the IBS, Grenoble. The project is entitled: “ 
DNA Repair Machinery: From fundamental research to drug design”. This funding covers a 
post-doc position for 2 years and running costs for the laboratory (60k€).  
• La Ligue contre le Cancer chose to further sponsor my ATIP-AVENIR research project by 
covering my salary for 3 years, starting in 2011. 
• In October 2011, I was awarded a 1-year grant (28k€) by the Département du Science du 
Vivant of the CEA for a project entitled: ‘Structural and Functional studies of Endonuclease 
III’ to initiate a project in collaboration with the Laboratoire Lésions des Acides Nucléiques 
from the CEA, Grenoble. 
• In January 2012, I was awarded a 2-year grant (50k€) by the Association pour la Recherche 
sur le Cancer (ARC) for a project entitled: ‘Structural studies of protein-DNA complexes 
involved in the recognition and repair of DNA damages’. 
 
Recent Presentations & Conference contributions 
• GTBio Protein Crystallography conference at Lille, November 2007. Oral presentation: 
Towards a better understanding of DNA repair in D. radiodurans. 
• 8th Winter Research Conference: Oxidative DNA Damage, at Les Houches, January 2009. 
Oral presentation: Structure-Function studies of DNA repair proteins from Deinococcus 
radiodurans. 
• EMBO Meeting in Amsterdam, August 2009. Poster: Structural and mutational studies of 
Deinococcus radiodurans UvrA2 provide insight into DNA binding and damage recognition. 
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• Invited speaker at the Institut de Biologie Structurale in Grenoble, November 2009. Title: 
Towards a better understanding of DNA repair in the extreme-radiation resistant bacterium D. 
radiodurans. 
• Invited speaker at the Plasticité des Génomes 2010 Meeting in Grenoble, November 2010. 
Title: Les mécanismes de réparation de l’ADN chez D. radiodurans. 
• Invited speaker at the Journées Scientifiques de l’IBS, June 2011. Title: Structural Insight 
into DNA Repair. 
• Invited speaker at the Institut de Génétique et Microbiologie, Orsay, October 2012. Title: 
Études structurales et fonctionnelles des protéines Uvr de Deinococcus radiodurans. 
• Invited speaker at the Institut de Biologie et Chimie des Protéines, Lyon, December 2012. 
Title: Études structurales et fonctionnelles des mécanismes de réparation de l’ADN. 
 
Additional scientific activities 
• Member of the Partnership for Structural Biology Laboratory Committee from 2006-2011. 
• Member of the editorial board of the Partnership for Structural Biology Newsletter as the 
ESRF representative from 2007 to 2010, and now as the IBS representative. 
• Local contact on the MX beamlines (ID14, ID23 & ID29) at the ESRF from 2003 to 2011. 
• Member of the CN4 scientific commission of the Fondation ARC that evaluates research 
proposals, since 2012. 
• Reviewer for Current Biology and Biochemistry Journals. 
• Reviewer of ANR grant proposals. 
• Member of the thesis advisory committee of four PhD students 
 
B. Supervision of research staff 
Supervision of trainees and Master’s students: 
2012   Supervision of Sandrine Gauthier, Master1 student (4 months) 
   Functional characterisation of human Endonuclease III (hNTH1) 
2011  Supervision of Catherine Surr, summer trainee (Licence; 2 months) 
   Purification of D. radiodurans UvrC fragments 
2010  Co-supervision of Virginie Carbonell, Master2 Pro student (6 months) 
  Structural characterisation of 4-coumarate:coA ligase 
2007-2008 Co-supervision of Therese Johansson, Master’s student from Sweden (1 year) 
 7 
  Characterisation of D. radiodurans UvrB 
2006-2007 Supervision of Sarah Cake, BSc. Degree placement student (1 year) 
  Characterisation of the Par proteins from D. radiodurans 
2005  Supervision of Sofia Caria, Master’s student from Portugal (1 year) 
  Purification and crystallisation of D. radiodurans UvrA2 
Supervision of laboratory technicians: 
2009-2010 Supervision of Ulrike Kapp, technician 
  Structural studies of H. pylori DnaB helicase 
2007-2011 Supervision of Samira Acajjaoui, technician 
  Structural and functional studies of D. radiodurans Uvr proteins 
Supervision of graduate students: 
2010-present Co-supervision of Morgane Lourdin, PhD student, UJF, Grenoble 
  Characterisation of Deinococcus radiodurans Fpg enzyme 
2009-present Co-supervision of Kjertsi Lien, visiting PhD student for 6 months (Norway) 
  Structural studies of key DNA repair enzymes from D. radiodurans 
2008-2012 Co-supervision of Aili Sarre, PhD student (Norway) 
  Structural and functional studies of D. radiodurans EndoIII enzymes 
2008-2012 Supervision of Simone Pellegrino, PhD student. Thesis defended 28th Feb2012. 
  Structural studies of D. radiodurans RecN protein 
Supervision of post-docs: 
2011-present  Supervision of Meike Stelter, post-doc  
Structural studies of protein-DNA complexes involved in DNA repair 
2008-2011  Supervision of Tobias Klar, post-doc 
   Characterisation of the UvrA and UvrB proteins from D. radiodurans 
2008-2011  Supervision of Jens Radzimanowski, post-doc 
   Structural studies of the RecOR complex from D. radiodurans 
2008-2011  Supervision of Meike Stelter, post-doc 
   Structural studies of HpDnaB and DrUvrD helicases 
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Part II: Past research (2003-2011) 
Introduction 
 My PhD work (1998-2002) was carried out at the European Molecular Biology 
Laboratory (EMBL) Grenoble Outstation in the group of Winfried Weissenhorn and included 
two separate studies. The first project investigated the role of human ADAM 12, a member of 
the growing ADAM (A Disintegrin And Metalloproteinase) protein family, involved in cell-
cell and cell-matrix interactions, while the second and principal project of my PhD focused on 
the study of the matrix protein (VP40) of Ebola virus, a key protein essential for efficient viral 
assembly and budding. The use of various techniques (X-ray crystallography, electron 
microscopy, biochemical assays and cell biology) allowed us to study the cellular localisation 
of VP40 and its role in virus budding, to characterise its ability to oligomerise and to identify 
cellular binding partners (Figure 1). This work led to several publications in peer-reviewed 
journals (Scianimanico, Schoehn et al. 2000; Timmins, Scianimanico et al. 2001; Gomis-
Roth, Dessen et al. 2003; Timmins, Schoehn et al. 2003a; Timmins, Schoehn et al. 2003b; 
Hoenen, Volchkov et al. 2005). In 2004, we were invited to write a review entitled: 
“Structural studies on the Ebola virus matrix protein VP40 indicate that matrix proteins of 
enveloped RNA viruses are analogues but not homologues” for publication in FEMS 
Microbiology Letters (Timmins, Ruigrok et al. 2004).  
 
Figure 1: Characterisation of the Ebola virus matrix protein, VP40. (A) Electron micrograph 
of an isolated virus-like particle secreted by mammalian cells overexpressing VP40. (B) 
Negative stain electron micrograph of oligomeric VP40 revealing the presence of both 
hexamers and octamers. (C) Surface Plasmon resonance study of the interactions of VP40 
with the WW domains of a human ubiquitin ligase, Nedd4. (D) Crystal structure of octameric 
VP40. 
 In 2003, I joined the Macromolecular Crystallography Group (now named the Structural 
Biology Group) at the European Synchrotron Radiation Facility (ESRF) on a European 
collaborative project (FP6 project: EURAMAN) to study the GlcNAc-phosphotransferase 
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enzyme, responsible for targeting of proteins to lysosomes and associated with lysosomal 
storage diseases. The project focused on the gamma-subunit of this enzyme, believed to be 
required for specific recognition of lysosomal proteins. Initial work was carried out in 
Norway (one month visit) and the subsequent development of a large-scale overexpression 
system in mammalian cells (293T cells) was achieved in Grenoble. Successful expression and 
purification of this protein allowed us to raise specific antibodies, which could then be used 
for further biochemical assays (search for binding partners) and cellular localisation studies 
(electron microscopy using gold-labelled antibodies). The project is still ongoing and is being 
carried out by collaborators in Norway and Finland. 
 During my post-doctoral work at ESRF, I rapidly became involved in the ongoing 
Structural genomics project that focused on a radiation-resistant bacterium, Deinococcus 
radiodurans. This Gram-positive, red-pigmented, non-sporulating and non-pathogenic 
bacterium (Figure 2) can withstand very high doses of ionising radiation (over 10,000 Gy), 
which introduce several hundred double-strand breaks into its genome (Cox and Battista 
2005).  
 
 
 
 
 
 
 
Figure 2: (A) Scanning Electron Microscope image of Deinococcus radiodurans (false-
colour, by Peggy A. O’Cain and Margaret C. Henk, Louisiana State; modified by Peter Reid, 
The University of Edinburgh). The scale bar represents 1µM. (B) Typical survival curves for 
D. radiodurans, E. coli, human and cockroach.  
The robustness of this bacterium is due to a combination of factors: (i) cell structure and 
nucleoid organisation (Levin-Zaidman, Englander et al. 2003), (ii) strong oxidative stress 
resistance mechanisms (including high Manganese content) (Daly, Gaidamakova et al. 2007; 
Slade and Radman 2011) and (iii) an efficient and precise DNA repair system (Zahradka, 
Slade et al. 2006). This bacterium was of particular interest to a team working in a 
synchrotron – a powerful source of ionising radiation, in this case X-rays. 
 The main goal of the project in 2003 was to determine the crystal structures of selected 
protein targets (approximately 100 proteins) from D. radiodurans (see section B.1. below), 
but other methods available at the ESRF were also used and/or further developed to 
characterise this unusual bacterium (see section A.1. and A.2.). As the years passed, my 
involvement in the project increased and by 2006 I was the principal coordinator of the D. 
radiodurans research project and my interest focused on its remarkably efficient DNA repair 
repertoire (see section C).  
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A. D. radiodurans and synchrotron-based experiments 
 1. Irradiation experiments 
 In 2006, we made use of the ID17 medical beamline at ESRF to carry out an X-ray 
irradiation experiment on D. radiodurans cells. D. radiodurans is a mesophile and is 
conventionally grown at 30ºC in rich medium with aeration. For this experiment, the cells 
were grown in either rich M53 medium or in minimal medium (MM) supplemented with 
Manganese and were subjected to various doses of X-rays: 0, 0.1, 0.5, 1, 5, 10, 15, 20 and 30 
kGy (Figure 3). After irradiation, the cells were grown again at 30ºC and samples were 
collected at 0, 3, 6 and 24 hours post-irradiation for further analysis.  
 
Figure 3: (A) Sample environment on ID17 beamline at ESRF. (B) 2 ml samples of D. 
radiodurans cells following irradiation with 0, 5, 10, 15, 20 and 30 kGy. The pink colour of 
D. radiodurans cells is due to the presence of deinoxanthin (a carotenoid). Irradiation of the 
cells significantly alters the colour of the cells.  
The goal of this experiment was to investigate the survival curve of D. radiodurans in 
different growth environments as a function of X-ray dose (Figure 4) and to produce cell 
samples for analysis of DNA damage and protein expression levels as a function of dose and 
recovery time post-irradiation. 
 
Figure 4: (A) Survival curves of D. radiodurans cells grown in rich M53 medium or minimal 
medium (MM) as a function of X-ray dose. The plotted data points correspond to the average 
of three independent measurements, except in the case of the highest dose (30 kGy) where 
only a single measurement could be made. (B) Growth curves of the non-irradiated and 
irradiated cells. The optical density at 600nm was measured at 0, 3, 6 and 24 hours after the 
irradiation of the cells. 
 As observed previously, our experiments confirmed that D. radiodurans withstands 
extremely high doses of ionising radiation and in this particular case, X-rays. Up to 5 kGy the 
viability of the irradiated cells is comparable to those of control cells and it is only above 10 
kGy that the viability starts to be affected. Our growth curves of the control and irradiated 
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cells also show that the cells arrest their growth for the first 3 hours post-irradiation, time 
during which they repair their largely fragmented genomes. Between 3 and 6 hours, upon 
completion of DNA repair, cells start growing again at rates similar to control cells. 
  2. Cell imaging 
 D. radiodurans is usually found in the form of diads or tetrads with an average cell 
diameter of 1 µm. Among the many advanced biological imaging methods available to date, 
there is currently no method that can image intact a-few-micron-thick samples in three 
dimensions (3D), reaching the resolution of 10 nanometres or better, without the risk of 
structural artefacts. The recently developed X-ray diffraction microscopy (XDM) technique 
has the potential to reach this goal (Miao, Charalambous et al. 1999). The high penetration 
power of X-rays allows probing thick samples without sectioning, while lens limitations, such 
as low efficiency or depth of focus, are no longer limiting factors to achieve high-resolution 
3D imaging. XDM is an imaging method based on diffraction. When the diffracted wave field 
from a sample is known at the far field, the image reconstruction is straightforward by an 
inverse Fourier transformation. Experimentally, only the amplitude of the wave field is 
available, as the phase is not measured. Phase retrieval algorithms have been developed that 
impose a priori known information as constraints iteratively to find a solution (Elser 2003). 
However, the convergence of the phasing algorithm is strongly dependent on the quality of 
the diffraction pattern. The general procedure outlined above has been used very successfully 
with radiation-hard samples, but obtaining quality data from weakly scattering biological 
samples, especially in the frozen state, has been challenging (Sayre 2008). For successful 
imaging, one needs to preserve the samples in the amorphous ice state throughout sample 
handling and data collection. 
 In collaboration with scientists from the ID10C beamline at ESRF, we used D. 
radiodurans cells to develop cryo-XDM, which combined plunge-freezing of samples with 
data collection in the cryogenic-temperature gas environment (Figure 5A), as routinely used 
on macromolecular crystallography beamlines. For these experiments, D. radiodurans cells 
were grown in TGY medium at 30ºC for 3 to 4 hours and exponentially growing cells were 
resuspended in 10% glycerol just before plunge freezing in liquid ethane. The cells were 
frozen in nylon sample loops. The ID10C beamline was set-up to produce coherent 8 keV X-
ray illumination on the sample and the diffraction data were collected on a charge-coupled 
device (CCD).  
 
Figure 5: (A) Experimental setup at ID10C, ESRF. The shaded region indicates a vacuum 
environment. The non-vacuum sample environment is a 40 cm long section of the beam path 
housing slits, a sample goniometer, an on-axis visualization video microscope by MAATEL, 
and an Oxford Cryostream cooler 700 series. (B) Optical microscope image of D. 
radiodurans with 320x magnification. (C) An assembled diffraction pattern of a frozen-
hydrated D. radiodurans tetrad. The total exposure time is 7 min using focused 8 keV X-rays. 
The measured diffraction signals at the edge of the array extend to 30 nm spatial half period 
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in the sample. (D) 2D reconstruction of D. radiodurans. The arrows at ‘‘s’’ highlight a 
diagonal structure which may be the septum and the areas labelled with ‘‘n’’ indicate 
possible nucleoid regions. 
Figure 5C shows a full diffraction pattern measured from frozen-hydrated, unstained D. 
radiodurans. The estimated radiation dose is ~3x107 Gy and no signs of radiation damage 
were observed. The reconstruction shown in Figure 5D was obtained by averaging the final 
reconstructions from 10 different random starts. The sample size is about 1.5 µm, calculated 
from the speckle size and reconstruction. Close observation suggests that the optically denser 
areas (labelled as ‘‘n’’) might be the nucleoid regions of the bacteria while ‘‘s’’ points out 
what may be the septa dividing the whole cell. The resolution in the current reconstruction is 
estimated to be 30 to 50 nm where features down to 30 nm are visible with a good contrast, 
but we believe that the technique can be refined to achieve higher resolution in the near 
future. This work was published in Physical Review Letters in 2009 (Lima, Wiegart et al. 
2009). 
 
B. Structural genomics approach 
 1. High-throughput methods 
At the end of the 1990’s almost simultaneous explosions in the techniques of protein 
production and purification, synchrotron-based macromolecular crystallography and 
bioinformatics led to the proposal of a new field of structural biology called structural 
genomics (SG) (Terwilliger 2000). At the core of SG projects was the perceived potential to 
rapidly produce, purify, crystallise and solve the crystal structures of many thousands of gene 
products from many different organisms. Significant investments in software developments 
and rapid access to synchrotron radiation facilities meant that structure elucidation was 
already much more straightforward than previously and so the major focus of SG became the 
ability to control high yield protein production procedures to provide material for X-ray 
crystallography.  
The structural genomics project initiated at the ESRF in 2002 aimed to solve 
structures of protein targets from D. radiodurans associated with its radiation resistance. 
Target selection was based on the available literature and knowledge of biological responses 
to irradiation, oxidative damage and desiccation. These criteria led to an initial set of proteins 
with a priori relevance either as part of a known functional category or as a protein unique to 
D. radiodurans. Membrane proteins were excluded from this study. Additionally, some gene 
products potentially allowing derivative-free crystal structure determination were selected. In 
these cases gene products were chosen based on their high sulphur content (at least 4% 
sulphur-containing residues) and a set of ten were chosen based on the putative presence of 
metals in the native protein (Figure 6).  
Initial cloning, expression and solubility assessment of these ~100 targets were 
outsourced to a start-up biotechnology company in Grenoble, Protein’eXpert (now named 
PX’ Therapeutics). All targets were cloned into a bacterial expression vector that produced 
proteins fused to a non-cleavable N-terminal His-tag. Expression was tested in different E. 
coli strains at either 37ºC or 15ºC in a highly automated manner. With this automatic 
screening process approximately 70% of the targets cloned produced visible expression (as 
tested on SDS-PAGE) at 37°C using E. coli BL21(DE3) and 50% produced soluble proteins. 
Whenever successful, these clones were then used by the ESRF Structural Biology (SB) 
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Group in order to pursue large-scale expression to produce sufficient quantities of protein for 
crystallisation trials.  
 
Figure 6: (A) Flowchart illustrating the process used to select ~100 targets from the D. 
radiodurans genome. (B) Functional distribution of these target proteins. (C) Frequency with 
which these targets were found in other bacterial genomes.   
In 2004, a round of manual expression and solubility tests were carried out at the 
ESRF in order to validate the results of the automatic screening. This rapidly revealed 
significant differences in results, showing a generally higher level of expression and solubility 
compared to those obtained using the automated micro batch technique. We therefore decided 
to carry out systematic small-scale (manual) expression and solubility testing of all the clones 
(24 in total), which had not produced soluble proteins in the automatic screening. These tests 
were conducted at 20°C and various bacterial strains were evaluated. Both the levels of 
expression and solubility increased significantly following this manual screening procedure 
and these tests revealed that soluble protein could be obtained in at least one cell line for all of 
these recalcitrant targets. 
 We then subjected all these targets to medium-scale protein production (0.5 L 
cultures). In these, soluble product was obtained in more than 70% of the cases tested. This is 
rather less than the 100% success rate predicted in the small-scale tests and the differences 
observed in the production of soluble protein between the small- and medium-scale cultures 
are most likely the result of two phenomena: (i) an over-estimation of the soluble protein in 
the small-scale expression tests due to the use of SDS-PAGE as analysis tool and (ii) the 
significant changes in bacterial growth conditions when increasing sample volume from 5 ml 
to a 0.5 L culture, both of which are known to affect the level of expression and solubility of 
recombinant proteins (Sugar, Jenney et al. 2005). In over one third of the clones tested, a 
sufficient amount of protein was obtained from this medium-scale culture to carry out 
additional purification steps and set up crystallisation trials. 
 In 90% of cases, at least two purification steps were required to obtain the 
homogeneity suitable for crystallisation trials. A number of quality control steps were used to 
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ensure the protein sample was pure and homogeneous. Analytical size-exclusion 
chromatography was routinely used (in over 75% of cases) to assess both the quality of the 
protein samples and to investigate the oligomeric states of the targets. The dual role of gel 
filtration as a purification step and as a quality control/biochemical characterisation step 
makes it a very attractive tool when handling several proteins in parallel. Dynamic light 
scattering was also routinely used to check the polydispersity of the samples prior to 
crystallisation trials.  
 Crystallisation has been the most serious bottleneck encountered in SG projects. In 
this study, 33 proteins were expressed and purified in sufficient quantities for crystallisation 
to be attempted. A coarse screen of crystallisation conditions was set up using commercially 
available screens and initial hits optimised by a finer screen around the initial condition. For 
more than half the proteins studied robotic screening was used for initial crystallisation trials. 
However, in some cases manual screening resulted in crystallisation leads where robotic 
screening failed. This observation may be due to differences in drop handling and 
equilibration kinetics during the crystallisation process. The robot sets up 0.2 µl drops using 
the sitting-drop method, while the drops set up manually were larger (2 µl) and used the 
hanging-drop method. Of the 33 proteins that reached the crystallisation stage, 13 (40%) 
produced diffraction quality crystals (Figure 7). This ratio is similar to that observed in other 
laboratory scale structural genomics initiatives (Terwilliger 2000; Quevillon-Cheruel, 
Dominique et al. 2004; Segelke, Schafer et al. 2004; Moreland, Ashton et al. 2005) and can be 
explained by the trial-and-error, rather than strictly rational, approach to crystallisation used 
in this and other similar studies. A more systematic examination of the crystallisation phase 
diagram of each of the targets would possibly have increased our yield of crystallised 
proteins.  
 
Figure 7: Status of the laboratory-scale D. radiodurans structural genomics project in 2006. 
The major bottleneck was the crystallisation step. 
 The structure determination process was clearly not a limiting factor in this work and 
undoubtedly the proximity to synchrotron beamlines was essential in achieving this. Of the 13 
proteins crystallised, 12 have resulted in successful structure elucidation (Figure 7). The main 
structure determination method employed was by far experimental phasing using single-
wavelength anomalous dispersion (SAD). Five structures were determined by exploiting 
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metal ions intrinsic to the native protein (Zn2+ or Fe2+), three were solved using 
selenomethionine protein derivatives and one structure determination exploited sulphur as the 
anomalous scatterer. One of the 13 structures was solved using SIRAS, where a mercury 
compound was soaked into crystals and the three remaining structures were phased using 
molecular replacement methods. 
By 2006, the project had successfully cloned 71 and expressed 59 genes resulting in 
the determination of 13 protein structures (Leiros, Kozielski-Stuhrmann et al. 2004; Meunier-
Jamin, Kapp et al. 2004; Leiros, Moe et al. 2005; Leiros, Timmins et al. 2005; Timmins, 
Leiros et al. 2005; Dennis, Micossi et al. 2006; Moe, Leiros et al. 2006; Romao, Mitchell et 
al. 2006; Cuypers, Mitchell et al. 2007; Leiros and McSweeney 2007; Kapp, Macedo et al. 
2008), which compares well with other, larger scale projects. During the evolution of this 
project the emphasis of the study shifted from a strictly structural genomics project into a 
scientific evaluation of a number of important and grouped genes. This had the consequence 
that low hanging fruit were sacrificed in order to allow projects of greater scientific interest to 
be pursued. The technology available was re-deployed to allow more intensive investigation 
in a project-orientated approach. 
 2. Crystal structure of sugar-bound MTHase 
 Within the context of the D. radiodurans structural genomics project, in 2003 I 
crystallised and determined the structure of an enzyme involved in trehalose synthesis, named 
maltooligosyltrehalose trehalohydrolase (or MTHase). This work was published in Journal of 
Molecular Biology in 2005 (Timmins, Leiros et al. 2005). 
 Trehalose is a non-reducing α-1,1-linked disaccharide (α-D-glucopyranosyl-1,1-α-D-
glucopyranose) that accumulates in organisms under stress conditions. Trehalose appears to 
be the most effective stabiliser of proteins and membranes during prolonged dehydration by 
serving as a water substitute (Elbein, Pan et al. 2003). Studies have also revealed that 
trehalose can act as a free radical scavenger and thus protect proteins and DNA from damage 
caused by oxygen radicals. Since there is no terrestrial environment that generates high doses 
of radiation, the radiation resistance of D. radiodurans has been proposed to have arisen by 
selection for desiccation resistance (Mattimore and Battista 1996). The removal of water from 
a cell is a severe, often lethal stress. During desiccation, cell metabolism is arrested 
completely and subsequently needs to be fully recovered during rehydration, and extensive 
damage is caused to DNA (including double-strand breaks), proteins and lipid membranes. 
Damage to DNA and proteins is mediated mostly through reactive oxygen species. 
  At least three different pathways for the biological synthesis of trehalose have been 
described. The best-studied pathway involving the enzyme trehalose phosphate synthase is 
missing in D. radiodurans.  Instead, D. radiodurans appears to use two alternative pathways 
for trehalose biosynthesis. It possesses the gene encoding trehalose synthase (DR2036), which 
has been shown to catalyse the conversion of the α-1,4-glycosidic linkage of maltose to the α-
1,1-glycosidic bond of trehalose. In addition, D. radiodurans has two extra genes for 
trehalose metabolism, which encode a maltooligosyltrehalose synthase (DR0463; MTSase) 
and a maltooligosyltrehalose trehalohydrolase (DR0464; MTHase). Together these proteins 
catalyse a two-step reaction that breaks down maltooligosaccharides or starch into trehalose 
(Figure 8A). MTSase converts the glycosidic bond between the last two glucose moieties 
from an α-1,4-linkage to an α-1,1-linkage, thus producing a non-reducing glycosyl 
trehaloside. The second enzyme (MTHase) cleaves the α-1,4-linkage adjacent to the α-1,1- 
glycosidic bond to release free trehalose. 
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 D. radiodurans MTHase was expressed in BL21 (DE3) Star cells with an N-terminal 
His-tag and was purified on a Ni-chelating sepharose, followed by a size-exclusion 
chromatography. Large crystals (600 µm x 150 µm x 20 µm) were obtained using the 
hanging-drop method in 18-15% (w/v) PEG 2000 MME, 0.1 M Tris-HCl pH 8.5, 0.05-0.2 M 
MgCl2 and 10% glycerol. A high resolution (1.1 Å) data set was collected on ID29 at ESRF 
(Table 1). The crystals belonged to the orthorhombic space group P212121 with cell 
dimensions a=59.6Å, b=66.6Å and c=152.5Å and contained one molecule per asymmetric 
unit. For structure determination, seleno-methionine-substituted protein was prepared that 
crystallised in the same conditions as the native and these crystals were used for a SAD 
experiment performed at the selenium-absorption edge on ID29. Anomalous data to a 
resolution of 2.0Å were collected (Table 1). Crystals containing either MTHase-trehalose or 
MTHase-maltose complexes, were obtained in similar conditions as the apo-enzyme, but with 
either 25% (w/v) trehalose or 20% (w/v) maltose added to the mother liquor and data was 
collected on these crystals to respectively 1.5 and 1.2 Å (Table 1). 
Table 1: Statistics from the data collections.  
X-ray statistics 
SeMet-
MTHase 
Native 
MTHase 
MTHase-
trehalose 
MTHase-
maltose 
Beamline ID29 ID29 ID14-EH2 ID14-EH2 
Wavelength (Å) 0.979 1.005 0.933 0.933 
Space group P212121 P212121 P212121 P212121 
PDB Entry Code - 2BHU 2BHY 2BHZ 
Unit cell (Å) 
a=59.82   
b=66.51  
c=152.01 
a=59.58   
b=66.62  
c=152.51 
a=60.03   
b=66.56  
c=153.14 
a=59.14   
b=66.56  
c=153.50 
Resolution (Å) 
 
55.90-2.00 
(2.11-2.00) 
46.93-1.10 
(1.16-1.10) 
20.00-1.50 
(1.58-1.50) 
20.00-1.20 
(1.26-1.20) 
No. of unique reflections 41 475 216 600 98 045 187 653 
Multiplicity 3.6 (3.3) 2.6 (1.8) 3.4 (2.7) 3.8 (2.7) 
Completeness (%) 99.2 (95.8) 88.3 (82.9) 99.1 (95.8) 99.2 (95.2) 
Mean (<I> /<σI>) 21.2 (15.9) 7.1 (2.3) 14.8 (3.9) 12.6 (2.5) 
Rsym (%) a 4.6 (5.6) 8.2 (38.6) 4.8 (26.4) 5.9 (39.3) 
Ranom (%) b 6.1 (7.5)    
FOMSADc  0.554    
FOMSFd 0.84 (1.6Å)    
 
The numbers in parentheses represent values in the highest of 10 resolution shells, and the resolution limits for 
these are also indicated. 
a Rsym = (∑h∑i | Ii (h) - <I(h)>| ) / (∑h∑i Ii (h) ), where Ii(h) is the ith measurement of reflection h and <I(h)> is the 
weighted mean of all measurements of h. 
b Ranom= ∑( |<I+> -  <I->| ) / (∑(<I+> + <I-> ) ), where <I> is the mean intensity of the reflection. 
c FOMSAD = Figure of merit after SAD phasing  
d FOMSF = Figure of merit after solvent flattening and phase extension to 1.6 Å using an additional native data 
set   
 MTHase is a monomer and displays three major domains (Figure 8B): an N-terminal 
domain (domain N) that consists of an eight-stranded immunoglobulin-like Greek key fold , a 
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central catalytic (β/α)8 barrel domain (domain A) and a C-terminal domain (domain C) that 
consists of a six-stranded γ-crystallin-type fold. The N domain is connected to domain A via a 
long, fully extended linker and packs tightly against the N-terminal side of the (β/α)8 barrel, 
while domain C packs against the C-terminal side of the (β/α)8 barrel. Three additional 
subdomains (domain B, D and E) protrude from the central domain A (Figure 9). The 
domains are named according to α-amylase nomenclature (MacGregor, Janecek et al. 2001). 
Subdomain E, which is missing in most members of the α-amylase family, consists of a long 
α-helix (Eα1) in MTHase, followed by two smaller ones (Eα2 and Eα3) that connect Aβ8 
and Aα8 of domain A. This long α-helix (Eα1) lies above the active site and the loop 
connecting this helix to the following shorter helices is missing in the final refined model, 
implying that this structural unit is highly flexible. Three strictly conserved carboxylic acid 
residues are found in family 13 glycosidases, which have been shown by mutagenesis studies 
to be the essential catalytic residues (Sogaard, Kadziola et al. 1993). Sequence and structural 
comparison have revealed that these residues correspond to Asp275, Glu308 and Asp400 in 
MTHase. These catalytic residues are situated on the top of the (β/α)8 barrel. Asp275 and 
Glu308 are located at the C-terminal tips of β-strands Aβ4 and Aβ5 respectively, while 
Asp400 is contributed by a short α-helix linking Aβ7 to Aα7. The positions of the waters in 
the active site pocket of MTHase are highly conserved.  
 
Figure 8: (A) Schematic diagram of the two-step breakdown of maltopentaose into trehalose 
and maltotriose catalysed by MTSase and MTHase. (B) Ribbon representations of the apo-
form of MTHase. Each domain is represented in a different colour and is labelled. The 
catalytic residues are illustrated in ball-and-sticks. The disordered loop (residues 473-481) is 
shown as a dashed line and Αα7 and Eα1 helices are indicated by arrows. 
 Comparison of our crystal structures obtained for the apo- and sugar-bound MTHase 
reveals that the overall conformation of MTHase in complex with sugars is essentially the 
same as the native structure. The MTHase-trehalose complex structure was solved to 1.5Å 
resolution and seven trehalose molecules and two single glucose rings could be built into the 
electron density maps. Four of the trehalose molecules are involved in crystal packing. One 
trehalose molecule (Tre1) sits at the entry of the channel leading to the active site and a 
second trehalose molecule and two single glucose rings could be modelled into electron 
density at the exit of the substrate binding cleft, thus indicating a possible pathway for product 
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release. Most importantly, a trehalose molecule (Tre2) could be modelled into the +1 and +2 
subsites of the substrate binding cleft (Figure 9B). The major difference between a 
maltooligosaccharide and a maltooligotrehaloside substrate is the orientation of the terminal 
glucose moiety, implying that the +2 subsite is the most critical region for specific substrate 
recognition (Figure 9A). This is indeed the case in the MTHase-trehalose complex. The 
presence of trehalose (Tre2) in the +1 and +2 subsites of the MTHase-trehalose complex has 
allowed the identification of the residues involved in the selective binding of the α-1,1-linked 
sugar, trehalose, as opposed to other maltooligosaccharides. These crucial residues are located 
in the A and D domains. The sugar units in the +1 and +2 subsites are both specifically 
recognised by an extensive hydrogen-bonding network involving many water molecules. A 
majority of the residues involved in the specific recognition of the sugar ring in the +2 site are 
conserved within the MTHase family. Importantly, the His332 Nε2 atom hydrogen-bonds 
directly to the O6 atoms of the two sugar units of the bound trehalose molecule. This 
interaction is trehalose specific, since the presence of both O6 atoms at hydrogen-bonding 
distance from His332 Nε2 could only occur with a α-1,1-linked disaccharide.  
 
Figure 9: (A) Schematic diagram of the maltooligotrehaloside-binding subsites in MTHase. 
(B) Illustration of the electrostatic surface potential of MTHase in its substrate-bound form 
(complexed with maltose), contoured at ±20 kT/e in which red and blue represent negative 
and positive potentials respectively. The bound sugars are presented in ball-and-stick models 
in yellow (trehalose) and green (maltose), and arrows point to the entry and exit channels. 
The sugar-binding subsites are labelled in white. The secondary structure elements, Eα1, Bβ1 
and Bβ2, are visible through the electrostatic potential surface. (C) Ribbon representation of 
the conformational change in subdomain E of MTHase upon binding to Mal3 (native 
conformation in blue and maltose-bound conformation in yellow).  
 The structure of MTHase in complex with maltose (an α-1,4-linked disaccharide, 
which mimics a short portion of a maltooligosaccharide chain) was solved to 1.2Å resolution. 
As in the case of trehalose, the final refined model contains seven sugar molecules. Three of 
these maltose molecules are involved in crystal packing, two of which are found in similar 
positions to the trehalose. Another maltose molecule makes extensive contacts with the long 
linker that joins the N domain to the A domain and with the bottom of the (β/α)8 barrel. This 
interaction is most likely contributing to the stability of the protein, but may not be 
biologically relevant, since the binding site is far from the active site. Additionally, there is a 
maltose (Mal1) in the +2 and +3 subsites (Figure 9B). The ring in the +2 site makes similar 
hydrogen-bonding interactions as the trehalose ring at the equivalent position, however the 
maltose ring is not stabilised by the hydrophobic stacking against His310. The +3 subsite is 
located at the exit of the active site, in close proximity to where the glucose moiety was found 
in the MTHase-trehalose complex. Moreover, two maltose moieties were found in the entry 
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channel leading to the active site. One of these molecules (Mal2) is located very close to the 
entry site, with one of its rings closely overlapping with the trehalose molecule at the 
equivalent position (corresponding to the -6 subsite). The second maltose (Mal3), however, is 
tightly bound at the -2 and -3 subsites. For this interaction to take place, the long α-helix of 
subdomain E (Eα1) undergoes a significant conformational change in which it closes down 
on the maltose, in order to trap it in the channel leading to the active site. This new 
conformation of Eα1 is now kinked at residue 464, resulting in a 20° bend in the helix and a 
6.4 Å-displacement of the Cα atom of Phe472 (Figure 9C).  
 The three-dimensional crystal structures of MTHase in its apo-form and in complex 
with both maltose and trehalose revealed the mode of substrate recognition of MTHase. This 
is most likely shared by other members of the subfamily of MTHase enzymes, since most of 
the critical residues are conserved. Unlike other members of the glycosidase family 13, 
MTHase undergoes a significant conformational change upon substrate binding, in order to 
guide the sugar chain into the active site.  The presence of this unusual trehalose synthesis 
pathway in the extreme radiation and desiccation-resistant bacterium D. radiodurans suggests 
that this additional pathway may be essential, especially as the ‘classical’ pathway involving 
trehalose-phosphate synthase is missing. The rapid breakdown of the most widely available 
source of maltodextrins in nature, i.e. soluble starch, would be an efficient mechanism to 
rapidly produce trehalose in response to environmental stress. 
Crystals of seleno-methionine-substituted MTHase were later used for a study of the 
effect of X-ray dose rate on radiation damage during macromolecular crystallography data 
collection. This work led to a publication in 2006 (Leiros, Timmins et al. 2006). 
 
C. DNA Repair in D. radiodurans 
 1. Double-strand break repair 
  1.1. RecO protein 
 In 2004, within the context of the ongoing D. radiodurans structural genomics project, 
I began to work on the expression, purification and crystallisation of RecO, an essential DNA 
repair protein involved in the repair of the most lethal type of DNA damage, namely double-
strand breaks. In prokaryotes, homologous recombination, in addition to its fundamental role 
in genetic diversification of bacterial genomes, plays an essential role in the repair of a variety 
of DNA damage, including double-strand breaks (Figure 10) (Kuzminov 1999; Michel, 
Grompone et al. 2004). In E. coli, the initiation of homologous recombination can be carried 
out by either the RecBCD or the RecFOR proteins; in both cases these proteins act as 
mediators for RecA binding to single-stranded DNA (ssDNA) in order to allow for 
homologous strand invasion (Kowalczykowski, Dixon et al. 1994). Comparative studies of 
bacterial genomes have revealed that many genomes display an incomplete set of DNA repair 
systems. While RecBCD has been shown to be the major DNA recombination pathway in E. 
coli, the RecFOR pathway actually appears to be the more frequent pathway in bacterial 
genomes (Rocha, Cornet et al. 2005). RecR, along with RecA and the resolvases, have been 
found to be nearly ubiquitous in bacteria, suggesting they must be playing essential roles. 
RecO and RecF are less well conserved and appear to be missing in a number of species. 
In contrast to the (E. coli) RecBCD pathway the mechanism of recombinational repair 
mediated by the RecFOR pathway is still only poorly understood. The major difference 
between these two recombination pathways lies in the initiation step, also known as 
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presynapsis. RecFOR displaces ssDNA binding protein (SSB) prior to loading of RecA onto 
the ssDNA, while RecBCD directly catalyses the latter step. In addition, RecBCD is known to 
function as a single holoenzyme (Singleton, Dillingham et al. 2004), whereas it is still unclear 
whether RecFOR exists as a functional complex in vivo and how it mediates presynapsis. It 
has been shown that RecF, RecO and RecR are all required for protecting the nascent lagging 
strand when replication forks are stalled on UV-radiation induced damage sites. The absence 
of any of the RecFOR genes causes E. coli to become both hypersensitive to UV radiation and 
to display extensive degradation in the nascent lagging strand, suggesting that they form an 
epistatic group (Chow and Courcelle 2004). 
 
Figure 10: DNA double-strand break (DSB) repair through homologous recombination. 
DSBs introduced by DNA damaging agents are processed to a single-stranded region with a 
3′ overhang by a nuclease, a helicase or both. RecA is loaded by RecBCD or RecFOR onto 
the single-stranded DNA to form a nucleoprotein filament that searches for the homologous 
duplex DNA. After the search has been successfully completed, DNA strand exchange 
generates a joint molecule between the homologous damaged and undamaged duplex DNAs. 
DNA synthesis, requiring a DNA polymerase, its accessory factors and a ligase, restores the 
missing information. Finally, resolution of crossed DNA strands (Holliday junctions) by a 
resolvase yields two intact duplex DNAs. (Figure adapted from (Kanaar, Hoeijmakers et al. 
1998)). 
  RecR from D. radiodurans has been found to form tetramers in a ring-like structure 
(Lee, Kim et al. 2004). A central hole in the tetramer has a diameter of 30 Å, and is suited for 
binding double-stranded DNA (dsDNA). In the crystal structure of RecR, two such tetramers 
are interlocked and it is therefore believed that RecR tetramers can open and close in order to 
bind DNA. The RecFOR complex is specific for the dsDNA-ssDNA junction in the lagging 
strand of DNA at a stalled replication fork. Mapping this specificity into the individual 
components of the RecFOR complex is crucial in understanding the ongoing processes at 
such sites. As a first step in understanding the structural aspects of its involvement in DNA 
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repair, we determined the first crystal structure of a RecO protein (Figure 11) and identified 
the regions of RecO involved in DNA binding (Figure 12). This work was published in 
EMBO Journal in 2005 (Leiros, Timmins et al. 2005).  
 
Figure 11: (A) Ribbon illustrations of the secondary structure elements in RecO. α-Helices 
are shown in red and β-strands in yellow. The zinc atom in the zinc-finger motif is illustrated 
as a cyan sphere. (B) OB-fold of RecO, coloured in rainbow colours ranging from blue at the 
N-terminus to red at the C-terminus. The nucleotide-interacting residues of OB domains are 
generally found in the cleft on the right-hand side of the displayed domain. Residues in the 
β1–β2 loop and in the β4–β5 loop line this cleft. (C) Ribbon illustration of the zinc-finger in 
RecO. The four cysteine residues coordinating the zinc atom are illustrated in a ball-and-stick 
presentation and the zinc atom is shown as a cyan sphere. The electron density maps are 
2mFo-DFC maps contoured at 2σ (blue) and 7σ (red), respectively. The cysteine residues 
and the zinc atom were all omitted from the refinement. 
 D. radiodurans RecO (drRecO) was expressed in E. coli with an N-terminal His-tag, 
purified and crystallised in either 0.2 M calcium acetate, 8% (w/v) PEG 20,000, 8% (w/v) 
PEG 550 MME, buffered with 0.1 M Tris-HCl at pH 8.5, or 0.8 M sodium formate, 10% 
(w/v) PEG 8000, 10% (w/v) PEG 1000, buffered with 0.1 M Tris-HCl at pH 7.5. A first data 
set was collected to 2.4 Å resolution and indicated the presence of an anomalous scatterer in 
the crystal. A XANES (X-ray absorption near edge structure) analysis on ID14-4 at the ESRF 
confirmed this scatterer to be zinc. The structure was subsequently solved by the SAD method 
using data collected to 2.7 Å at the zinc absorption edge (Table 2). drRecO is composed of an 
N-terminal oligonucleotide/oligosaccharide binding (OB) fold region, a three-helix bundle, a 
Cys4 zinc finger motif and finally a group of four helices spatially inserted between the three-
helix bundle and the zinc finger motif. The OB fold domain and zinc finger motif reside at 
opposite ends of the protein with the α-helices clustered in the central part (Figure 11A).  
 Using only the OB fold domain as a search template, DALI gave good scores for 
several nucleotide-binding proteins, with the best match being for human and E. coli SSB 
proteins, followed by the breast cancer susceptibility gene 2 encoded protein (BRCA2), which 
also aligns well to the OB fold domain of drRecO. Within the OB fold, ssDNA binding is 
generally mediated by three distinct structural elements: the β1–β2 loop, the β4–β5 loop and 
the C-terminal part of β3, where the first provides positively charged residues to form ion-
pair(s) with the ssDNA phosphodiester backbone and the latter two each provide one 
conserved aromatic moiety (Bochkarev and Bochkareva 2004) (Figure 11B). In drRecO, 
positively charged residues occupy similar positions. In all the compared SSB proteins, there 
are at least two aromatic residues that have been shown to be important in ssDNA binding. In 
drRecO, no such aromatic residues can be found and there could be a tendency for 
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substitution of aromatic residues in SSB into positively charged residues in drRecO. Among 
RecO proteins, R16 and K35 in drRecO are conserved in being positively charged, thus 
further strengthening this possibility. 
Table 2: Data collection, structure solution and refinement statistics. Numbers in parenthesis 
are for data with a high-resolution cut-off at 4Å. ♣: Total/Protein/Water/Zinc.  
Dataset Peak Remote 
Data Collection statistics:   
Beamline ID14-4 ID14-1 
Wavelength (Å) 1.2827 0.934 
Resolution range (Å) 19.9-2.7 (2.85-2.70) 48.5-2.4 (2.53-2.40) 
Rsym (%) 9.3 (48.1) 6.2 (55.2) 
Multiplicity 8.3 (8.3) 2.3 (2.3) 
Mean I/σI 17.8 (4.1) 8.5 (1.7) 
Completeness (%) 99.7 (100.0) 98.8 (99.7) 
Space group C2 C2 
Unit cell parameters            
(a, b, c and β) 
134.7Å, 52.1Å, 
100.7Å and 106.4º 
134.4Å, 52.4Å, 
101.1Å and 106.3º 
Refinement statistics:   
# Atoms ♣ - 3557/3532/23/2 
B-factors ♣ - 53/56/43/46 
Rfree (%) - 26.7 (36.0) 
Rwork (%) - 22.5 (33.0) 
Geometry:   
Bonds (Å) - 0.010 
Angles (°) - 1.324 
 
 Zinc-fingers have long been considered as important mediators of protein–DNA 
interactions (Branden and Tooze 1991). Typically, they have the secondary structure 
succession β–β–α where the α-helix contacts DNA through major groove interactions. In 
drRecO, the α-helix is not formed (Figure 11C) and the importance of this zinc-finger motif 
is questionable as the E. coli and T. thermophilus RecO proteins both lack the C-terminal 
zinc-finger motif found in many bacterial RecO proteins. 
 The DNA binding properties of drRecO were subsequently investigated by 
electrophoretic mobility shift assays (EMSA) and an extensive mutational study of RecO 
(Figure 12).  Non-sequence specific protein-DNA interactions are predominantly either of a 
hydrophobic character, where aromatic or aliphatic residues contact DNA bases, or of an 
ionic character, where polar or positively charged residues contact the negatively charged 
phosphate backbone. E. coli RecO has previously been shown to interact with both ssDNA 
and dsDNA (Luisi-DeLuca and Kolodner 1994). In our study, we show that drRecO also 
interacts with both ssDNA and dsDNA oligonucleotides and with supercoiled plasmid DNA. 
Sequence alignments and secondary structure predictions of RecO proteins from other 
organisms indicated that the overall structure may be conserved even in RecO proteins that 
lack the zinc finger found in drRecO, suggesting that the zinc finger motif in drRecO may 
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serve mainly as a structural scaffold for maintaining the rigidity of the protein, rather than as a 
mediator of protein-protein or protein-DNA interactions. However, when EDTA was added to 
our EMSAs in order to disrupt the zinc finger, the DNA-binding was highly affected, 
although not totally abolished, indicating that the zinc-finger may contribute in part to 
drRecO-DNA binding. Electrostatic surface potentials highlight two regions of drRecO 
having pronounced positive charges, i) a ridge in the α5-α6 region, which is close to the zinc 
finger and non-conserved among RecO proteins, is exposed to solvent and very rich in 
positively charged residues, and ii) a region in the OB-barrel, which appears to be conserved 
between RecO proteins and is rich in positively charged residues (Figure 12C).  
Figure 12: (A) EMSA of drRecO. Lane M, DNA size markers in base pairs; lane 1, 0.2 µg 
supercoiled plasmid DNA (pcDNA3.1); lane 2, pcDNA3.1 + 40mM MgCl2; lane 3, pcDNA3.1 
+ 3 µg RecO; lane 4, pcDNA3.1 + RecO + 40m MgCl2; lanes 5–7, as for lane 4 but using 
0.05, 0.5 and 2 µg RecO, respectively; lane 8, as for lane 2; lane 9, pcDNA3.1 + 5 µg BSA; 
lane 10, pcDNA3.1 + 5 µg BSA + 40mM MgCl2. (B) EMSA of mutant RecO proteins. Lane 1, 
0.2 µg supercoiled plasmid DNA (pcDNA3.1); lane 2, pcDNA3.1 + 40mM MgCl2 + 5 µg 
RecO; lanes 3–14, as for lane 2, but using 5 µg of the mutant indicated above the lanes; lane 
15, as for lane 2, but using 5 µg BSA. The ribbon illustration on the right indicates the 
location of the mutations on the structure of drRecO. (C) Models for dsDNA interacting with 
RecO based on the DNA-binding studies and mutational analysis. Two alternative binding 
sites involving the OB barrel (bottom) and a positive patch (190-RHAVRRTVR-200) unique 
for drRecO ending at the zinc-finger (top) are shown. 
 Based on these findings, 16 mutants of drRecO were made, of which 12 were 
successfully purified and used in DNA-binding studies. Positively charged residues in both of 
the indicated regions of the protein were mutated into Ala and/or Glu. As both positive 
regions cover a large area, mutating positively charged residues into Ala may not be sufficient 
to abolish all DNA-binding in these regions. Mutation into Glu was therefore chosen in some 
cases in order to generate repulsion between the mutant proteins and DNA, hopefully without 
compromising the stability of the protein. The results of the DNA-binding study on mutated 
drRecO show that the DNA-binding affinity of mutant RecO proteins is reduced compared to 
wild-type drRecO and in some cases, no residual DNA-binding was observed (Figure 12B). 
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The mutations with the most pronounced effect on DNA-binding were R16E, K35E/R39E 
and K35E/R195E/R196E, strongly indicating that the OB-fold region is particularly important 
for DNA binding in drRecO, but that the second site is also involved to a lesser extent in 
DNA binding. 
 Since the RecFOR complex is specific for the ssDNA-dsDNA junction in a stalled 
replication fork, while the individual RecR and RecO proteins can interact with both ssDNA 
and dsDNA, formation of a molecular complex between the proteins appears to be necessary 
in order to obtain the specificity for the ssDNA-dsDNA junction in damaged DNA. In 2005, 
we therefore decided to focus our efforts on the study of the RecO-RecR protein complex 
from D. radiodurans and to gradually move away from the structural genomics approach. 
  1.2. RecOR complex 
 At the time, there was evidence that E. coli RecO and RecR formed a stable complex 
and together could remove SSB and allow RecA loading in the absence of RecF, suggesting 
that RecF is (at least partially) dispensable for this process (Umezu and Kolodner 1994). E. 
coli RecR is a dimer in solution (Hegde, Qin et al. 1996) and the two proteins are suggested to 
form a complex in a 1:1 molar ratio, presumably in the form of a 2:2 heterotetramer (Umezu 
and Kolodner 1994). In contrast, drRecR has been shown to be a tetramer or an octamer in 
solution in a concentration dependent manner (Lee, Kim et al. 2004).  
 The gene encoding D. radiodurans RecR (drRecR) had been cloned along with the 
drRecO gene as part of the D. radiodurans structural genomics project into a bacterial 
expression vector with an N-terminal His-tag. To isolate the RecO-RecR (RecOR) complex, 
cells expressing drRecO were mixed and lysed with cells expressing drRecR, and the soluble 
fraction of the cell lysate was purified by Ni-affinity chromatography, followed by ion-
exchange and size-exclusion chromatography (SEC). In the final SEC step, the RecOR 
complex eluted as a single peak (elution volume: 12.1 ml) corresponding to a molecular 
weight of approximately 150–160 kDa. RecO and RecR alone eluted later from the size 
exclusion column at 17.1 and 13.5 ml, respectively, in agreement with their calculated 
molecular weights (26 and 95 kDa). The ratio of drRecR/drRecO in the RecOR complex was 
estimated by comparison with known amounts of individually purified drRecR and drRecO 
on SDS–PAGE, and was found to be in a 2:1 ratio, probably in the form of a 4:2 
heterohexamer, which best agrees with its molecular weight derived from SEC. 
Table 3: Data collection statistics.  
Data collection  
Space group C2 
Unit cell (Å/°) a=144.0, b=83.2, c=66.6, 
β=106.9 
Resolution range (Å) 45-3.8 (4.0-3.8) 
Number of unique reflections 7194 
Redundancy 3.1 (2.1) 
Rsym (%)  13.6 (63.7) 
Completeness (%) 95.9 (95.9) 
Mean I/σ(I) 6.5 (1.4) 
Wilson B-value (Å2) 96.0 
Numbers in parenthesis are for data with a high-resolution cut-off at 4Å 
 27 
 Crystals of the RecOR complex were obtained using the hanging-drop method by 
mixing 1 µl of protein at 12 mg/ml with 1 µl of reservoir solution (0.1 M MES pH 6.5, 10% 
dioxane, 1.6 M Ammonium sulphate). X-ray intensity data was collected on ID14-2 at the 
ESRF (Table 3). The crystal used for data collection belonged to the monoclinic space group 
C2 and had unit cell dimensions of a=144.0Å, b=83.2Å, c=66.6Å, β=106.9°. Diffraction was 
observed to a maximum resolution of about 3.8Å. Molecular replacement (MR) searches were 
performed using one monomer of drRecR (pdb1VDD) and one monomer of drRecO 
(pdb1W3S) as search models. Phaser found a unique solution with no symmetry-generated 
clashes. With a limited observation-to-parameter-ratio, refinement was terminated after a 
single round of rigid-body refinement (Rwork/Rfree of 45.9%/44.3%, respectively) and 
subsequent manual rebuilding. Although the drRecOR complex structure is limited to 3.8 Å 
resolution, the corresponding maps are of overall good quality for the protein backbone, also 
revealing regions (mainly in RecR) that had to be remodelled due to complex formation. 
 
Figure 13: (A) Crystal structure of the hetero-hexameric drRecOR complex as reconsitituted 
by symmetry. drRecO is coloured in blue and drRecR molecules are coloured in gold. (B) 
Ribbon representation of the heterotrimeric drRecOR assembly present in the asymmetric 
unit. The structural elements of drRecO and drRecR are indicated. (C) Surface representation 
of drRecR indicating in blue the residues involved in protein-protein interactions with 
drRecO. Selected residues from the interface are labelled on one of the drRecR monomers. 
(D) Surface representation of drRecO indicating in gold the residues involved in protein-
protein interactions with drRecR. Selected residues from the interface are labelled.  
 The drRecOR complex has a 2:1 molecular ratio of drRecR to drRecO, where the 
content of the crystallographic asymmetric unit is a heterotrimer (Figure 13B). The C2 space 
group symmetry operator (-X,Y,-Z) generates the most probable biologically relevant 
heterohexameric molecular unit. By this symmetry operator, the tetrameric structure 
previously described for drRecR (Lee, Kim et al. 2004) is reconstructed, and the estimated 
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molecular weight of such a complex is consistent with its SEC elution profile. This entity thus 
consists of a heterohexamer of two drRecO molecules and four drRecR molecules (Figure 
13A). The drRecO molecules are rather unexpectedly positioned on either side of the 
tetrameric ring of drRecR, obstructing access to the interior of the ring. In this complex, the 
N-terminal OB-fold domains of each of the two drRecO molecules point towards the interior 
of the drRecR ring. The accessible surface area lost for one monomer of drRecO when 
binding to the tetramer of drRecR was calculated to be around 1500Å2, or 14% of the total 
accessible surface area for a monomer of drRecO, thus well within the representative range 
found for protein-protein complexes.  
 Most of the drRecR residues contributing to complex formation are located around its 
central hole, while those of drRecO are clustered on one side of the OB-fold domain and its 
neighbouring α-helix (Figure 13C and D). The OB-fold domain of drRecO contacts residues 
from both the N-terminal Helix-hairpin-Helix (HhH) motif and the C-terminal region, 
including the Walker B motif of drRecR. Both these regions in drRecR participate in domain 
swapping with neighbouring molecules and are thus also critical for stabilisation of the 
tetrameric structure of drRecR. drRecO also contacts the Toprim domain of drRecR. The 
interactions are mostly of hydrophobic character. Relatively few intermolecular hydrogen 
bonds or potential ion pairs were found. Only two of the latter were identified between 
drRecO and the drRecR tetramer: RecO-His93 to RecR-Glu146 (MolA) and RecO-His65 to 
RecR-Asp182 (MolD). All the regions of drRecR responsible for interacting with drRecO are 
strongly conserved in RecR proteins, including Glu146 and Asp182. In addition ionic 
interactions between residues Asp22 and Arg39 of symmetry-related drRecO molecules also 
contribute to the overall stability of the biological complex, as they form drRecO-drRecO 
interactions across the interior of the ring.  
 To validate our low-resolution crystal structure and verify the importance of the ionic 
interaction between His93 from drRecO and Glu146 from drRecR, we mutated His93 to Glu. 
This H93E mutant drRecO was no longer able to form a stable complex with wild-type 
drRecR. drRecO His93 and drRecR Glu146 are therefore essential in maintaining the hetero-
hexameric assembly. Glu146 is highly conserved in RecR proteins and contributes to a 
characteristic acidic surface patch found in Toprim domains (Aravind, Leipe et al. 1998). 
Recent work by Honda et al also identified the equivalent glutamate residue (Glu144) of T. 
thermophilus RecR (ttRecR) as being critical for its interaction with ttRecO (Honda, Inoue et 
al. 2006). In this study, mutation of ttRecR Glu144 to Ala resulted in a non-functional RecR 
protein that could no longer facilitate the loading of RecA onto SSB-coated ssDNA. Two 
independent studies thus show the importance of this ionic interaction for the stability of the 
RecOR complex, and consequently for its function in RecA loading onto ssDNA. While most 
of the contacts between drRecR and drRecO are of hydrophobic nature, the ionic interactions 
appear to contribute significantly to the overall stability of the complex. RecR, unlike RecO, 
is highly conserved throughout bacteria and the observation that the residues responsible for 
binding to RecO are also strongly conserved suggests that this protein-protein interface may 
well be observed in other bacteria. 
  Since both drRecO and drRecR had been shown to interact with plasmid DNA, we 
carried out similar EMSAs with the purified drRecOR complex. Addition of drRecOR to 
plasmid DNA led to a significant retardation of the plasmid DNA, which was further 
enhanced in the absence of Mg2+ (Figure 14A). Ten mutant complexes of drRecOR were used 
for DNA binding studies. In the case of drRecR, two potential DNA binding sites were 
mutated: (i) K23 and R27 located in the N-terminal HhH motif and (ii) D182 and E183 at the 
C-terminus of the Walker B motif. Single and double mutations of K23 and R27 to Glu 
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interfere with DNA binding, but only in the absence of Mg2+. For all three of these complexes, 
however, DNA binding is maintained in the presence of Mg2+. The double mutation of K23 
and R27 to Ala, however, fully disrupts DNA binding even in the presence of Mg2+ (Figure 
14B). This finding suggests that these two residues are essential for drRecOR DNA binding, 
but that Mg2+ coordination by the introduced Glu residues is compensating, at least in part, for 
the K23E/R27E mutations. The second DNA binding site (D182/E183) was proposed by Lee 
et al to be involved in Mg2+ coordination, therefore mutations to both Arg and Ala were 
prepared. However, only the double mutant D182A/E183A was soluble and could be used for 
the DNA binding study. This mutant was found to retain DNA binding, leading to a 
significant band shift (Figure 14B) that is very similar to that obtained for wild-type drRecOR 
complex.  
 
Figure 14: (A) EMSA analysis of drRecO, drRecR and drRecOR binding to supercoiled 
plasmid DNA. Lanes 1 and 2 correspond to plasmid DNA alone in the presence and absence 
of 40mM MgCl2. 1 and 5 µg of each of the proteins were added to the DNA in the presence of 
40mM MgCl2 and separated by EMSA (lanes 3-4 for drRecO, lanes 6-7 for drRecR, lanes 9-
10 for drRecOR and lanes 12-13 for BSA). In addition, in lanes 5, 8, 11 and 14, 5 µg of each 
of the proteins was mixed with plasmid in the absence of MgCl2. (B) Mutant drRecOR-
plasmid binding. Lanes 1 and 2 correspond to supercoiled plasmid DNA alone in the 
presence and absence of 40mM MgCl2. Lanes 3-22 correspond to the analysis of the binding 
of drRecOR mutants (lanes 3, 4 wtRecO-RecR K23E; lanes 5, 6 wtRecO-RecR K27E; lanes 7, 
8 wtRecO-RecR K23E/R27E; lanes 9, 10 wtRecO-RecR K23A/R27A; lanes 11, 12 wtRecO-
RecR D182A/E183A; lanes 13, 14 RecO-R16E-wtRecR, lanes 15, 16 RecO-R39E-wtRecR, 
lanes 17, 18 RecO-R35E/R39E-wtRecR, lanes 19, 20 RecO-R35E/R195E/R196E-wtRecR, 
lanes 21, 22 RecO-R195E/R196E-wtRecR) to plasmid DNA, while lanes 23 and 24 
correspond to the wild-type complex. All reactions were prepared both with (odd numbers) 
and without (even numbers) MgCl2. (C) Four types of DNA (dsDNA, two 3’overhanging 
DNA, 3’-OH1 (+7nt) and 3’-OH2 (+15nt), and ssDNA) were mixed with wild-type drRecOR 
at various protein:DNA ratios (0.5:1, 1:1 and 2:1) and were analysed by EMSA. In the 
second panel drRecOR was mixed with 3’-OH2 at a 2:1 ratio in the absence and presence of 
either MgCl2 alone or MgCl2 and ATP. In the third panel drRecOR was mixed with 3’-OH2 
and 5’-OH2 at various protein:DNA ratios (0.5:1, 1:1 and 2:1)  
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 In addition, several complexes were prepared by combining mutant drRecO proteins 
with wild-type drRecR. These include mutations in the two previously proposed DNA 
binding regions of drRecO: the OB-fold domain and the C-terminal positively charged ridge 
(Leiros, Timmins et al. 2005). Unlike the drRecR mutants, DNA binding of these complexes 
is strongly affected by all the mutations in drRecO, particularly in the presence of Mg2+ 
(Figure 14B). In particular, mutations in the OB-barrel completely abolish DNA binding in 
the presence of Mg2+. Regardless of the presence or not of Mg2+, the double OB-barrel 
(K35E/R39E) drRecO mutant complex no longer binds DNA, while the drRecO double 
mutant (R195E/R196E) seems to retain some DNA binding ability.  
 EMSA studies were also carried out with various DNA oligonucleotides, forming 
either single-stranded, double-stranded, 3’overhanging (OH1 and OH2 with respectively 7 
base and 15 base overhangs) or 5’overhanging (15 base overhang) DNA substrates. drRecO 
alone shows preferential binding to single-stranded DNA (and thus also binds to a lesser 
extent to both 3’ and 5’ overhanging DNA) and drRecR shows no detectable binding to these 
short oligonucleotides (Figure 14C). Wild-type drRecOR displays a clear preference for 
binding to 3’overhanging DNA compared to 5’overhanging, single- or double-stranded DNA. 
The highest affinity is seen for the longer 15-mer 3’overhang (Figure 14C). This binding was 
unaffected by the addition of the divalent cation, Mg2+, and ATP. Four of the mutant 
drRecOR complexes that showed severely impaired binding to plasmid DNA were tested for 
binding to single-stranded and double-stranded oligonucleotides and to the 15-mer 
3’overhanging DNA substrate (OH2). Three of these four mutants here again displayed very 
weak binding to all DNA substrates. Unexpectedly, the mutant complex consisting of the 
double drRecO mutant R195E/R196E associated with wild-type drRecR exhibited an 
increased binding relative to wild-type drRecOR (Figure 14C). None of the mutant complexes 
displayed a clear preference for one of the DNA substrates. 
 While the structure observed is consistent with the drRecOR complex observed in 
solution, it is also unexpected. Lee et al proposed that drRecR may act as a non-sliding DNA 
clamp, which could accommodate dsDNA within its central hole (Lee, Kim et al. 2004). In 
the drRecOR complex, RecO reduces access to the interior of the ring, suggesting that such a 
complex, if functional, must most likely adopt a different mode of DNA binding. Based on 
our mutagenesis studies, within the RecOR complex both drRecR and drRecO provide key 
residues involved in binding to DNA; in drRecR two positively charged amino acids, K23 
and R27, located in the HhH motif are essential for drRecOR-DNA interactions, as are two 
residues, K35 and R39, found in the OB-fold domain of drRecO (Figure 15A). Interestingly, 
mutating one of these two sites was sufficient to fully disrupt plasmid DNA binding, 
suggesting that both sites are needed for stable association of drRecOR with DNA. In both 
cases, these residues had been shown to be critical for the binding of the individual drRecO 
and drRecR proteins to dsDNA. In contrast additional regions of either drRecR (such as 
Asp182) or drRecO (positively-charged ridge at the C-terminus; residues Arg195 and 
Arg196) had been shown to be involved in DNA binding in the individual proteins, but only 
appear to be minor contributors to DNA binding within the context of the RecOR complex.  
 The preferred DNA substrate of the complex was identified as being dsDNA with a 
3’overhang, such as those encountered at ssDNA-dsDNA junctions in the lagging strand of 
stalled replication forks. These junctions are believed to be the sites of action of RecF and 
RecOR in vivo (Morimatsu and Kowalczykowski 2003). The individual drRecO and drRecR 
proteins show a very different DNA binding pattern to that observed for drRecOR. drRecO 
alone displays preferential binding to ssDNA and drRecR shows no detectable interaction 
with either ssDNA and dsDNA oligonucleotides under these conditions. In addition, mutating 
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the DNA binding sites of either drRecO or drRecR also resulted in mutant complexes that no 
longer displayed preferential binding to 3’overhanging DNA and retained weak binding to 
short fragments of both ssDNA and dsDNA. Selective binding to 3’overhanging DNA thus 
requires the assembly of RecO and RecR as a complex. This represents the first evidence that 
the drRecOR complex by itself displays a clear preference for binding to 3’overhanging DNA 
in the absence of RecF. However, this does not exclude a role for RecF in stabilising the 
assembly on ssDNA-dsDNA junctions through its interaction with RecR in vivo. 
 
Figure 15: Models of the drRecOR complex bound to 3’-overhanging DNA. (A) Surface 
representation of the drRecOR complex after removal of one drRecO molecule (blue). 
Residues of drRecOR required for DNA binding are shown in red. (B) Ribbon representation 
of the drRecOR complex with one drRecO molecule replaced by a dsDNA fragment with a 
3’overhanging strand.  
 These findings indicate that a structural rearrangement of the complex needs to take 
place in order for DNA to interact with residues located both inside the ring of drRecR and in 
the OB-fold domain of drRecO. We carried out chemical cross-linking and native gel 
electrophoresis studies of drRecOR in the presence and absence of 3’overhanging dsDNA  
and these studies suggested that drRecOR most likely undergoes both local conformational 
changes and a larger architectural reorganisation upon addition of DNA. Displacement of one 
of the two RecO molecules would leave enough space for a 3’overhanging strand of DNA to 
pass through the RecR ring and to interact with the OB-fold of the second RecO molecule 
(Figure 15B). In this model, the ssDNA-dsDNA junction interacts with the crucial residues 
from both RecO and RecR.  
The steps involved in RecOR-mediated assembly of RecA onto ssDNA are not known in 
great detail. Upon assembly at ssDNA-dsDNA junctions, structural rearrangements may occur 
as a result of protein-protein and/or protein-DNA interactions between the various partners. 
The RecOR complex assembly may be affected by the interaction of RecR with RecF and 
RecO with SSB upon DNA binding. This may subsequently induce a conformational change 
in either RecR or RecO, resulting in the displacement of a RecO molecule and the stable 
assembly of RecOR on stalled replication forks. In the case of ttRecR it was recently shown 
that Glu144 plays an essential role in the formation of both the RecOR and the RecFR 
complexes (Honda, Inoue et al. 2006). RecO and RecF may thus be competing for a common 
binding site on RecR, in which case the relative affinity of RecO and RecF for RecR may be 
central to these events. This relative affinity may be species-specific since RecO and RecF 
proteins are less conserved. This process may also be regulated by the nucleotide-bound state 
of RecF in order to control the assembly of RecA onto ssDNA. The ATPase activity of RecF 
may provide the necessary energy required for such structural rearrangements. A better 
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understanding of the processes regulating complex formation between these partners will 
certainly help in establishing the detailed sequence of events leading to the assembly of RecA 
onto ssDNA. The three-dimensional structures of the individual proteins have served as solid 
frameworks to identify residues or regions potentially involved in either protein-protein or 
protein-DNA interactions. However, structural and biochemical studies of the protein 
complexes, such as that of drRecOR, will now provide us with more valuable information 
regarding the functions of these proteins in vivo. 
Table 4 Data collection, refinement statistics 
Data collection  Refinement  
Space group P1 Resolution (Å) 3.34 
Cell dimensions  No. reflections 24006 
a, b, c (Å) 63.1, 93.1, 92.3 Rwork / Rfree (%) 22.5 / 27.7 
α, β, γ (°) 103.6.2, 110.4, 106.2 No. atoms  
Wavelength (Å) 0.9793     Protein 9156 
Resolution (Å) 83.07 – 3.34 (3.52 – 3.34)     Zn 6 
Rsym (%) 6.1 (35.1) B-factors  
I / σI 8.8 (2.0)     Protein 106.5 
Completeness (%) 94.2 (96.3)     Zn 96.7 
Redundancy 1.8 (1.8) R.m.s deviations  
   Bond lengths (Å) 0.009 
   Bond angles (°) 1.259 
*Values in parentheses are for highest-resolution shell.  
 This work was published in EMBO Journal in 2007 (Timmins, Leiros et al. 2007). In 
2008, a post-doctoral fellow, Jens Radzimanowski, was recruited to pursue this work under 
my supervision. After many unsuccessful trials, in 2011 crystals of a mutant drRecOR 
complex consisting of the double drRecR mutant K23A/R27A associated with wild-type 
RecO were obtained that diffracted to a maximal resolution of 3.3 Å (Table 4). The structure 
was solved by molecular replacement using the single drRecO and drRecR structures as 
search models. The crystals belonged to space group P1 and contained one hetero-hexameric 
drRecOR complex per asymmetric unit. This new crystal structure refined well using Phenix 
and the final geometry and statistics are very satisfactory (Rfact=22.5% and Rfree=27.7%). In 
this crystal form drRecOR reveals a more open conformation in comparison to the previous 
crystal structure (Figure 16A and B) and in this new conformation displacement of a RecO 
molecule is no longer a prerequisite for accommodation of ssDNA through the RecR ring. 
Interestingly, the important interaction between His93 from drRecO and Glu146 from drRecR 
is retained in this new crystal structure. 
Extensive small-angle X-ray (SAXS) and neutron (SANS) scattering data were also 
collected on drRecR and drRecOR alone and in the presence of DNA in order to determine 
the solution structures of drRecR and drRecOR. These data revealed that drRecR is actually a 
dimer in solution (Figure 16C and D) and not a tetramer or an octamer as previously reported 
(Lee, Kim et al. 2004). These higher order oligomers were most likely artifacts of the high 
protein concentrations used for crystallisation of RecR. The SAXS/SANS study of drRecOR 
confirmed that drRecOR was indeed a hetero-hexamer in solution and the solution structure 
agrees with the two available crystal structures, indicating that both of these conformations 
may occur in solution. These results indicate that tetramerisation of drRecR may therefore be 
favoured by the binding to RecO. Finally, our SANS data suggest that the drRecOR complex 
bound to ssDNA and dsDNA maintains its four-to-two stoichiometry and indicate that the 
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DNA is bound in the inside of the complex. A manuscript describing this multi-resolution 
study of the RecOR complex is in preparation (J. Radzimanowski et al, 2012). 
 
Figure 16: (A) Ribbon illustration of the structure of drRecOR (P1 space group). drRecR 
molecules are coloured pink and red, while drRecO proteins are coloured blue. (B) Overlay 
of the two drRecOR crystal structures. The P1 structure is coloured as in A, while the original 
C2 structure is coloured in gold. (C) Overlay of the experimental small-angle X-ray 
scattering curve obtained for drRecR (red) with the theoretical curve derived from a dimer of 
drRecR (blue line). (D) Ab initio model (space-filling model) derived from the SAXS data 
overlayed with the crystal structure of dimeric drRecR. 
  1.3. RecN protein 
In 2008, Simone Pellegrino joined the ESRF Structural Biology Group as a PhD 
student to work under my supervision on the study of RecN, a protein proposed to be 
involved in the early steps of DSB repair. DSB recognition and the initial response to DNA 
damage are poorly characterised processes in bacteria. In eukaryotes, the central DSB 
response factor is the MRN complex consisting of Mre11/Rad50/Nbs1 (van den Bosch, Bree 
et al. 2003). This multifunctional complex triggers the cellular response to DNA damage, 
prepares the DNA ends for subsequent strand-exchange processes via its multiple nuclease 
activities and is implicated in tethering of DNA ends and chromatids (Lamarche, Orazio et al. 
2010). Structural homologues of Mre11 and Rad50 are found in all three kingdoms of life but 
their roles do not appear to be conserved. Prokaryotic MR (Mre11/Rad50) complexes, also 
known as SbcCD complexes, have been implicated in processing of DNA ends and removal 
of DNA hairpin secondary structures during and after DNA replication (Cromie and Leach 
2001; Connelly and Leach 2002). SbcC and its eukaryotic homologue, Rad50, belong to the 
SMC (structural maintenance of chromosomes) family that includes proteins involved in 
sister chromosome cohesion, chromosome condensation and chromosome segregation 
(Graumann 2001; Hirano 2005). SMC proteins share a common domain organisation in which 
the N and C-terminal domains associate to form a globular ATP binding cassette (ABC)-like 
nucleotide binding domain (NBD) and the central region forms a long coiled-coil (Figure 
17A). Different organisms possess different numbers of SMC-like proteins. In addition to 
SbcC, many bacteria possess two additional SMC-like proteins, MukB and RecN (Graumann 
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and Knust 2009). Although the recN gene was originally identified in E. coli, it is found in 
most bacterial genomes. In E. coli, recN mutants display increased sensitivity to UV and γ-
irradiation and to the DNA damaging agent Mitomycin C (Sargentini and Smith 1986; Lloyd, 
Porton et al. 1988). There is now increasing evidence that RecN plays an essential role in 
DSB repair in several bacterial species (Funayama, Narumi et al. 1999; Kidane, Sanchez et al. 
2004; Kosa, Zdraveski et al. 2004; Wang and Maier 2008). 
 
Figure 17: (A) Schematic representation of SMC proteins. They consist of a globular Head 
domain corresponding to the N- and C-terminal domains, which exhibits ATPase activity, an 
anti-parallel coiled-coil region and hinge domain involved in SMC dimerisation. (B) 
Schematic diagram of the constructs used for structural, biophysical and biochemical 
analysis of RecN. The conserved ATP binidng motifs (Walker A, Walker B and signature 
sequence) are indicated. The N-terminal domain is coloured orange, the C-terminal domain 
green and the coiled-coil region yellow.  
However, the molecular mechanisms underlying these processes are still only poorly 
understood and at the start of S. Pellegrino’s project, there was no structural information 
available for RecN. Bacterial RecN proteins show an overall conservation in length and 
domain organisation, and display a clear set of conserved functional motifs, typical of ABC 
proteins: Walker A, Walker B and signature sequence (Figure 17B). RecN has indeed been 
shown to display weak ATPase activity that is stimulated in most cases by the addition of 
DNA (Sanchez and Alonso 2005; Grove, Wood et al. 2009; Reyes, Patidar et al. 2010). 
Bacillus subtilis RecN can bind to discrete ssDNA ends and increase the local concentration 
of such ends, leading to the formation of rosette-like structures (Sanchez, Cardenas et al. 
2008). To provide a structural framework for DSB recognition in bacteria, we carried out a 
high and low-resolution structural study of D. radiodurans RecN (drRecN) and characterised 
its in vitro activity. A manuscript describing this work is in revision in Structure (Pellegrino et 
al, 2012) and S. Pellegrino successfully defended his PhD thesis in February 2012. 
RecN was cloned into a bacterial expression vector for expression with a cleavable N-
terminal His-tag. RecN was expressed in E. coli and purified by Ni-NTA chromatography 
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followed by SEC in a buffer containing high salt (1M NaCl), a requirement for the stability of 
the protein. After many unsuccessful crystallisation trials, we decided to design alternative 
constructs of RecN to determine the structures of its individual domains. Bioinformatics and 
limited proteolysis experiments followed by mass spectrometry analysis allowed us to define 
the putative boundaries of RecN’s domains. Of these constructs, the fused N- and C-terminal 
domains with a 14-amino acid linker, named RecNHead and the coiled-coil construct 
containing residues 196-365, named RecNcc were successfully expressed and purified, 
yielding protein quantities and quality suitable for crystallisation trials (Figure 17B). The 
expression, purification, crystallisation and SAXS analysis of RecNHead and RecNcc were 
reported in two articles published in Acta Crystallographica Section F in 2012 (Pellegrino, de 
Sanctis et al. 2012; Pellegrino, Radzimanowski et al. 2012).  
Table 5 Data collection, phasing and refinement statistics. *Values in parentheses are for 
highest-resolution shell.  
 RecNhead 
SeMet 
RecNcc Native RecNcc SeMet RecNΔdd 
Data collection     
Space group P 21 P 21 P 21 I 2 
Cell dimensions     
a, b, c (Å) 129.9, 62.0, 
133.8 
73.2, 44.0, 133.6 71.6, 45.4, 133.4 72.2, 62.5, 145.5 
α, β, γ (°) 90.0, 102.7, 90.0 90.0, 97.7, 90.0 90.0, 97.5, 90.0 90.0, 98.4, 90.0 
Wavelength (Å) 0.9795 (peak) 0.992 0.9795 (peak) 0.873 
Resolution (Å) 50.00 – 3.00 
(3.16 – 3.00) 
52.5 – 2.04 
(2.15 – 2.04)  
66.2 – 2.28 
(2.40 – 2.28)  
47.03-4.00 
(4.15-4.00)  
Rsym (%) 12.4 (41.9) 7.0 (32.1) 7.4 (22.8) 28.4 (75.8) 
I / σI 9.2 (3.3) 8.4 (2.8) 12.4 (5.2) 3.8 (1.5) 
Completeness (%) 99.6 (100) 97.1 (98.2) 99.6 (99.7) 97.5 (93.8) 
Redundancy 5.1 (5.2) 2.4 (2.3) 4.4 (4.4) 3.0 (2.9) 
Refinement     
Resolution (Å) 49.5-3.00 45.9-2.04   47.0-4.00  
No. reflections 39868 49848  5182 
Rwork / Rfree† (%) 20.9/ 24.9 20.3 / 25.1  32.5 / 34.7  
No. atoms     
    Protein 10333 5019  3416 
    Water 116 444  0 
B-factors     
    Protein 43.49 31.74  70 
    Water 34.78 36.48  - 
R.m.s deviations     
 Bond lengths (Å) 0.004 0.003  0.003 
 Bond angles (°) 0.785 0.663  0.694 
 
Crystals of RecNHead were obtained by mixing 1µl of protein at 10mg/ml with 1µl of 
reservoir solution (0.1M Tris-HCl pH 7.5 and 25% PEG 3,350). Diffraction data were 
collected on ID23-2 at ESRF to a maximum resolution of 3.0 Å. The structure was solved 
using SAD data collected at the Se absorption edge on ID14-4 using crystals of 
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selenomethionine substituted protein diffracting also to a maximum resolution of 3.0 Å. The 
structure was built and refined using Coot and Phenix (Table 5). The asymmetric unit 
contains four RecNHead molecules. The RecNHead construct was designed in order to 
reconstitute the complete nucleotide-binding domain (NBD) of RecN. Structural analysis 
revealed that this construct also included some additional regions (Figure 18): the coiled-coil 
anchor motif, the beginning of the predicted coiled-coil region and a short C-terminal helix-
turn-helix (HTH) motif, which is unusual for Rad50 and SMC proteins. The overall structural 
organisation of RecNHead is similar to those of the head domains of S. cerevisiae SMC, T. 
maritima SMC and P. furiosus Rad50 proteins. RecNHead is a monomer both in solution (as 
seen by SAXS and multi-angle laser light scattering) and in the crystals. 
The NBD of RecNHead consists of two lobes, in which lobe I, formed primarily by 
the N-terminal domain of RecN, adopts a typical Rossmann fold, consisting of a six-stranded 
anti-parallel β-sheet (strands β1-β2 and β4-β7) wrapping around the Walker A containing α-
helix 1. Lobe II consists mostly of the C-terminal region of RecN and folds as a β−α−β 
sandwich in which helices α10-α12 pack against a mixed β-sheet (β3, β8, β12-β15). The N 
and C-terminal domains are held together by hydrogen-bonding interactions between β3 and 
β8 strands from the N-terminal domain and β12-β14 strands located in the C-terminal domain. 
The Walker-B motif is located on strand β12 and helix α10 contains the signature sequence, 
important for driving ATP-dependent NBD dimerisation (Altenberg 2003). The NBDs of 
RecN and other SMC or SMC-like proteins for which crystal structures are available only 
share a low overall sequence conservation (14% identity between RecN and pfRad50), but the 
residues responsible for ATP-binding (K67 in the Walker-A motif) and hydrolysis (D471 and 
E472 in the Walker-B motif) are strictly conserved and are located at similar positions in 
order to create half of the functional nucleotide binding pocket (Hopfner, Karcher et al. 2000). 
The signature sequence is also highly conserved, but unlike the Walker-A and B motifs, 
adopts a very different orientation, as a result of the rotation of the coiled-coil anchor motif 
relative to the NBD (Figure 18).  
The anchor motif is primarily composed of a three-stranded anti-parallel β-sheet (β9-
β11), helix α4 and two flexible linkers connecting β8 to α4, through a short helical turn (α3), 
and β11 to α11. Comparison with pfRad50 head domain reveals that the region connecting α2 
to α4 including β8, which is substituted by a short helix in Rad50, is poorly conserved. As a 
result the entire coiled-coil anchor motif, along with the signature sequence of RecNHead, 
undergo a ~60° rotation relative to their position in pfRad50. Helix α4 plays an essential role 
in guiding the positioning of the helices belonging to the coiled-coil region (α5 and α10) so as 
to be roughly orthogonal to the NBD.  
In order to investigate the ATP binding and hydrolysis activity of RecNHead, several 
point mutants were prepared targeting either the Walker A, Walker B or both motifs. A 
double mutant of RecNHead (RecNHeadK67A/E472Q) turned out to be of particular interest. Its 
elution profile from the SEC column, supported by dynamic light scattering (DLS) and multi-
angle laser light scattering (MALLS) measurements, indicated that it was dimeric both in the 
presence and absence of nucleotide. It also displayed a strong absorbance at 260nm (with a 
260/280 nm ratio of approximately 1), suggesting the presence of a bound nucleotide. SAXS 
measurements were performed on RecNHeadK67A/E472Q and the scattering curve (Figure 18) 
obtained from these measurements could be used to successfully build an ab initio model of 
the overall envelope (Figure 18). The Guinier approximation estimated the radius of gyration 
(Rg) to be 3.45 nm and the molecular weight (~70 kDa) derived from the scattering at zero 
angle (I0) was in agreement with the size of a dimer. Taking advantage of the available 
knowledge regarding ATP-binding sites (Hopfner and Tainer 2003) and our overall envelope, 
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we built a model of the dimer using the RecNHead crystal structure (Figure 18). The 
calculated theoretical scattering curve derived from this model was superimposed on the 
experimental SAXS curve. The excellent fit with a χ2 value of 1.56 indicates that this model 
describes very well the behavior of the protein in solution (Figure 18). In this model, the 
coiled-coil domains are located on either side of the two RecNHead monomers, that come 
together in a head-to-tail orientation to form two functional ATP-binding pockets as observed 
previously for dimerisation of NBDs. The Walker-A K67 and Walker-B E472 residues from 
one molecule form a functional ATP binding pocket with the signature sequence from the 
second molecule. In the structure of RecNHead, the signature sequence is situated only 9 Å 
away from the Walker-B motif, while this distance increases up to ~20 Å for SMC or Rad50 
head domains, suggesting that the two ATP binding pockets formed at the NBD dimerisation 
interface would be much closer together in the case of RecN compared to SMC or Rad50.  
Figure 18: (A) Crystal structure of RecNHead domain. The NBD formed by the N- and C-
terminal domains and the beginning of the coiled-coil region are coloured as in Figure 17B. 
The coiled-coil anchor domain is coloured red. (B) Overlay of RecNHead with the head 
domain of pfRad50 (grey) displaying a very good fit with root mean square deviations of 
1.61Å over 121 Cα. The coiled-coil anchor motif and the C-terminal HTH are indicated by 
dotted lines. (C) SAXS analysis of RecNHeadK67A/E472Q. Experimental curve averaged from 
two protein concentrations (in red). The theoretical curve (in blue) was derived from the 
model proposed in (D) and the Chi-square value of the fit is reported. In the upper right the 
pair distribution function (P(r)) relative to the experimental scattering curve is shown. (D) 
Model of RecNHeadK67A/E472Q head-to-tail dimer derived from our SAXS analysis. One 
molecule is coloured grey, while the second is coloured as in (A).  
The central region of RecN proteins is predicted to be a coiled-coil and to be involved 
in dimer formation (Graumann and Knust 2009). Sequence alignment of D. radiodurans 
RecN with other bacterial RecN proteins highlights how this domain is conserved in length 
but shows very low sequence identity (< 2%). We determined the crystal structure of RecNcc, 
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a construct corresponding to the coiled-coil domain of RecN (Figures 17B) at 2.0 Å resolution 
(Table 5). The structure consists of 6 α-helices (α5-α10) of varying lengths, which follow an 
anti-parallel arrangement (Figure 19A). RecNcc forms a stable dimer with a clear two-fold 
symmetry. The dimer interface is formed by residues located on helices α6-α8 interacting 
with their equivalent residues from the second monomer through an extended network of van 
der Waals interactions. The buried interface covers an area of ~1400 Å2 and involves 34 
residues. The anti-parallel coiled-coil arrangement of each RecNcc monomer is favoured by 
dipole and hydrogen-bonding interactions (Figure 19A): in particular the highly conserved 
E222 and R319 form a salt bridge that stabilises the packing of helix α6 against helix α9. As a 
result, the overall structure of RecNcc appears to be very rigid. Several loops located between 
helices α5-α6, α8-α9 and α9-α10 confer some degrees of freedom to the entire rod-like 
structure.  
 
Figure 19: (A) Crystal structure of the dimeric coiled-coil domain of RecN. A close-up view of 
the dimer interface is shown in the box. Residues involved in dimerisation are represented as 
sticks. Distances are reported for intermolecular ionic interactions that stabilise the anti-
parallel fold of the coiled-coil. (B) Crystal structure of RecNΔdd in which the N-terminal 
region is coloured red and the C-terminal domain is coloured light green. Helices α5 and α10 
are respectively ~75 and ~100 Å long and present large kinks that determine the orientation 
of the coiled-coil domain. A close-up view of the final electron density map (2Fo-FC map 
contoured at 1.5σ) is shown for the central region of the coiled-coil, which allowed us to 
obtain a full model of helices α5 and α10 that were only partially visible in our RecNHead 
and RecNcc structures.  
To confirm whether this dimerisation interface is relevant to dimer assembly in RecN, 
we characterised a deletion mutant (RecNΔdd) lacking helices α7 and α8. MALLS 
measurements were performed, confirming that RecNΔdd is a monomer in solution and we 
determined the crystal structure of RecNΔdd (Figure 19B) at a maximum resolution of 4.0 Å 
(Table 5). The electron density map allowed us to extend the long and kinked helices α5 and 
α10 belonging to the coiled-coil domain that were only partially present in the RecNHead 
structure. Coiled-coil domains of SMC and SMC-like proteins display very low sequence 
conservation but, in contrast, within a protein family are highly conserved in length. SMC 
proteins, for example, have coiled-coil regions of around 900 amino acids long (Melby, 
Ciampaglio et al. 1998), whereas bacterial RecN proteins have considerably shorter coiled-
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coils composed of only approximately 240 residues. Our crystal structure of the coiled-coil 
domain of RecN highlights the remarkable diversity of interfaces used for dimer formation 
among SMC, SMC-like and RecN proteins. Dimer assembly in SMCs and ecMukB involves 
mostly ionic interactions, whereas Rad50 dimerization is favoured by a zinc-hook motif and a 
small hydrophobic interface located between the Zn-hook and the coiled-coil (Hopfner, Craig 
et al. 2002). In RecN proteins, while this region is poorly conserved, the hydrophobic nature 
of the residues involved in dimer assembly is retained, indicating that this mode of 
dimerisation is most likely conserved within the RecN protein family.  
These three crystal structures of overlapping regions of drRecN were then used to 
assemble a complete quasi-atomic model of the full-length RecN monomer (Figure 20A). The 
resulting RecN monomer is very elongated (190 Å long). To analyse the oligomeric state of 
RecN in solution, we performed SEC coupled to on-line MALLS. RecN elutes as a 
homogeneous dimer with a molecular mass of 108 kDa in high salt buffer, while it tends to 
form heterogeneous higher order oligomers in lower salt conditions. SAXS studies were 
performed on RecN (Figure 20B) and the Rg was estimated to be ~9.5 nm, using the Guinier 
approximation. The molecular weight estimated from the I0 value is in agreement with a 
dimeric assembly of full-length RecN and the profile of the calculated Pair distribution 
function, characterized by a long tail at higher R values also clearly indicates that full-length 
RecN is an elongated molecule. A complete model of dimeric RecN (Figure 20C) was 
prepared using the model of monomeric RecN and the dimeric interface of RecNcc. In this 
model, the two head domains of RecN located ~300 Å apart face each other at the two 
extremities of the dimer and are twisted 180˚ apart. The theoretical scattering curve derived 
from this model showed a very good fit with the experimental SAXS data, giving an 
estimated χ2 value of 3.44 (Figure 20B).  
 
Figure 20: (A) Quasi-atomic model of RecN. (A) Superposition of RecNΔdd (light green) with 
RecNHead (dark red) and RecNcc (blue) resulted in very good fits with RMSD values of 1.06 
Å over 342 Cα for RecNHead and 1.01 Å over 89 Cα for RecNcc domain. (B) SAXS analysis 
of RecN in high salt conditions. The experimental curve (in red) is superposed with the 
theoretical curve (in blue) determined from the assembled model represented in (C). The 
goodness of fit (χ2) is reported. The Pair distribution function is displayed in the upper right 
square and suggests, from its shape, that the scattering molecule is very elongated (DMAX of 
31.5 nm). (C) Architecture of full-length RecN. One molecule of the dimer is coloured in 
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rainbow, starting from the N-terminus (light blue) to the C-terminus (red), while the other is 
coloured in grey. 
To better relate these structures to RecN’s functions, we carried out a number of in 
vitro activity assays on RecN, RecNHead and their Walker-A and B mutants (Figure 21). 
RecN displays a weak ATPase activity with a turnover rate (kcat) of 0.12 s-1 (Figure 21A). The 
enzyme kinetics data were best fit to an allosteric sigmoidal model, indicating that RecN has 
two cooperative ATP binding sites that do not follow simple Michaelis-Menten kinetics. This 
is in agreement with previously reported studies on RecN (Reyes, Patidar et al. 2010) and a 
number of SMC-like proteins (Hopfner, Karcher et al. 2000; Lammens, Schele et al. 2004; 
Lammens, Bemeleit et al. 2011). A titration of the ATPase activity as a function of protein 
concentration revealed that the isolated RecNHead domain shows a significantly reduced 
ATPase activity compared to the full-length RecN, suggesting that the coiled-coil region 
plays an important role in maintaining a basal ATPase activity. Introducing single and double 
mutations into the Walker-A and -B motifs of RecN resulted in severely reduced (K67A, 
E472A and K67A/E472A), or completely abolished (E472Q and K67A/E472Q) ATPase 
activity (Figure 21C), confirming that these residues are directly involved in the ATP binding 
and/or hydrolysis process in RecN. The activities of Walker-A and -B RecNHead mutants 
were similarly impaired.  
 
Figure 21: (A) ATPase activity of 3 µM RecN in the presence of increasing concentrations of 
ATP (0-4.25mM). Kinetic parameters derived from these data are shown. The data was best 
fit to an allosteric sigmoidal model, indicating that RecN has two (h coefficient) ATP binding 
sites and does not follow standard Michaelis-Menten kinetics. (B) DNA-stimulated ATPase 
rates of RecN and RecNHead. The ATPase activity of 3 µM RecN was measured in the 
presence of 0-12 µM linearized plasmid dsDNA and that of 15 µM RecNHead was measured 
in the presence of 0-30 µM dsDNA. The ATPase rates are given in µM ATP 
hydrolysed/min/µM RecN. (C) ATPase activities of 0.25 µM wild-type and mutant RecN 
(black bars) and of 15 µM wild-type and mutant RecNHead (grey bars). (D) Fluorescence 
anisotropy measurement of RecNHead binding to fluorescein 5’-end-labelled 50mer dsDNA. 
(E) DNA end-joining activity of 0-4 µM RecN on blunt-ended linearised pUC19 dsDNA 
plasmid. After incubation of the plasmid DNA with RecN and then with T4 DNA ligase, the 
DNA was purified and separated on an agarose gel. As indicated on the right of the gel, RecN 
favours the formation of plasmid multimers. Control plasmids were also loaded on these gels: 
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S, supercoiled plasmid and L, linearised plasmid. 
ATPase measurements conducted in the presence of increasing amounts of linear 
plasmid DNA also clearly indicated that the ATPase rates of both RecN and RecNHead were 
stimulated by dsDNA (Figure 21B). Calculation of the electrostatic surface potential of RecN 
reveals that its surface is largely dominated by negatively charged residues and only one 
positively charged region, located on the Head domain, was identified as a putative DNA-
binding motif. This patch consists of three arginine residues (R81, R120 and R133), two of 
which are highly conserved in RecN proteins, located on β7, α2 and the loop connecting α1 to 
β4 of the NBD. These residues are ideally positioned to interact with the negatively charged 
DNA backbone. Together with our biochemical results these findings indicate that the DNA 
binding properties of RecN most likely reside in the head domain of RecN. This was 
confirmed by recent fluorescence polarisation data that showed that isolated RecNHead 
domains could interact with fluorescein end-labelled dsDNA oligonucleotides displaying a Kd 
of 2.0±0.3 µM (Figure 21D). As with the ATPase activity of RecN, the DNA binding curve of 
RecNHead displays clear cooperativity.  
We then investigated the DNA end-joining activity of RecN. As previously reported 
(Reyes, Patidar et al. 2010), RecN displays a concentration-dependent cohesin-like activity 
resulting in a clear pattern of plasmid multimerization (Figure 21E). The Walker-A and –B 
mutants of RecN display mostly reduced DNA-end joining activity compared to wild-type 
RecN, favouring the accumulation of monomers, dimers and trimers. Nonetheless, it is quite 
clear that the mutations in the Walker-A and –B motifs have a much greater effect on the 
ATPase activity of RecN compared to its DNA end-joining activity. The plasmid 
multimerisation pattern obtained for the RecN mutants is reminiscent of the pattern observed 
previously for RecN in the presence of a non-hydrolysable analogue of ATP (Reyes, Patidar 
et al. 2010). These results suggest that the capacity to hydrolyse ATP is not an essential 
requirement for RecN-driven catalysis of plasmid multimerisation. However, impaired 
ATPase activity reduces the turnover of RecN and therefore the extent of multimerisation. 
The isolated RecNHead domain, in contrast to the full-length protein, was unable to promote 
DNA end-joining (Figure 21E). ATP-dependent head-head engagement appears to be 
essential for the DNA end-joining activity of RecN.  
Based on our structural and biochemical data, the head domains are very unlikely to 
engage to form a closed circular dimeric state as has been proposed for SMCs (Hirano 2002). 
RecN has a short and rigid coiled-coil, which differs from the high flexibility of the longer 
coiled-coil domains of SMC proteins (Hirano 2006). Instead, our data suggest a model in 
which dimeric RecN molecules, which constitute the building blocks, probably form 
polymers via head-head engagement (Figure 22). Such an assembly would be tightly 
regulated by the nucleotide-bound state of RecN. Our biochemical data suggests that the 
interaction of RecN’s head domain with dsDNA strongly favours head-head engagement and 
subsequent polymerisation of RecN along the DNA. We speculate that the assembly of such a 
helical filament across two broken ends would provide an efficient mechanism to hold these 
together until the DNA repair machinery is recruited to the sites of DSB. In this model, which 
has previously been proposed for bacterial SMCs (Hirano 2006), the homologous strands of 
DNA would be held together by RecN polymers and maintained sufficiently far away from 
each other by the coiled-coil domain acting as a molecular spacer, in order to avoid unwanted 
DNA end-joining. A similar mechanism has been proposed for cohesin and Rad50 (Hirano 
2002; Lammens, Bemeleit et al. 2011) but our results represent the first structural evidence 
for such a model. ATP hydrolysis would then be the trigger for disengagement of the head 
domains and disassembly of RecN from the DNA, in order to recycle RecN for a new round 
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of DNA tethering and to allow the DNA repair machinery to activate DNA strand exchange 
and homologous recombination (Figure 22). 
 
Figure 22: Model for DSB recognition by RecN. DSBs are recognised by RecN in the form of 
an open, elongated dimer. Recognition and binding to the DNA occurs through the individual 
head domains of RecN. Assembly on the DNA then favours nucleotide binding and head-head 
engagement, thus leading to the formation of tetramers and subsequently higher order 
oligomers as RecN polymerises into a helical filament that wraps around the damaged DNA 
and its sister chromatid (spatial separation between the two homologous strands corresponds 
to ~300Å). Head-head engagement of two RecN molecules on either side of the DSB would 
maintain the DNA ends close together and make them available for homologous 
recombination. Arrival of the repair machinery may stimulate ATP hydrolysis, which would 
lead to disengagement of the head domains and disassembly of the RecN filament. The 
released RecN would then be available for a new round of DSB recognition and homologous 
recombination could take place. 
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 2. Nucleotide excision repair 
 In 2004, the ESRF Structural Biology Group decided to initiate a new phase of their 
structural genomics project, which was more project-based. Twenty targets, including five 
DNA repair genes belonging to the Uvr (UV resistance) pathway, were selected for this new 
round of production. After an in-depth bioinformatics analysis of the genes and a careful 
design of the constructs on our side, the cloning and initial optimisation of expression and 
purification conditions were again outsourced to Protein’eXpert in Grenoble. The Uvr 
proteins (UvrA1, UvrA2, UvrB, UvrC and UvrD) were successfully cloned and expressed in 
E. coli and after one year in the hands of Protein’eXpert, the project returned to ESRF and in 
2005, together with a 1-year Masters’ student (Sofia Caria) I began working on the Uvr 
proteins from D. radiodurans.   
  2.1. UvrA proteins 
UvrA proteins are one of the key components of the nucleotide excision repair (NER) 
pathway responsible for the repair of the structurally diverse lesions caused by ultra-violet 
light which involves the recognition and removal of damaged DNA by a dual-incision event 
(reviewed in (Truglio, Croteau et al. 2006)). In the NER pathway in prokaryotes (Figure 23), 
it is generally accepted that UvrA, acting as a dimer together with UvrB, is responsible for 
DNA damage recognition. In addition, UvrA proteins on their own have been shown to bind 
preferentially to damaged DNA (Mazur and Grossman 1991; Thiagalingam and Grossman 
1991). After damage recognition, UvrA dissociates from the DNA, while UvrB forms a stable 
pre-incision complex upon sites of DNA damage. UvrC subsequently binds to the UvrB-DNA 
complex and incises the DNA first on the 3’ side, then on the 5’ side of the lesion (Sancar and 
Rupp 1983). The resulting 12 to 13 nucleotide fragment containing the damaged DNA is 
released by UvrD and the gap is then filled by DNA polymerase I and ligase.  
 
Figure 23: Schematic diagram describing the steps leading to repair of UV-induced DNA 
damage by the NER pathway in prokaryotes involving the UvrA, UvrB, UvrC and UvrD 
proteins. 
The availability of a large number of bacterial genomes has revealed that the UvrA 
family consists of five different classes (Goosen and Moolenaar 2008). Of these classes the 
best studied is the class I UvrA. The primary differences between the various class members 
 44 
are either deletion of specific domains (class II and class III) or gene duplication (class IV) or 
both (class V). Class I and class II UvrA genes show a high degree of sequence similarity, 
where the deletion observed is restricted to the UvrB recognition/interaction domain. D. 
radiodurans encodes two UvrA proteins, the class I drUvrA1 and class II drUvrA2. In D. 
radiodurans the expression of both of these genes is up regulated during the early to mid-
phase following irradiation (Liu, Zhou et al. 2003). Despite this lack of a UvrB binding 
domain, there is evidence that class II UvrAs play a minor role in DNA repair and tolerance to 
DNA damaging agents, such as UV or chemical treatment (Tanaka, Narumi et al. 2005; Shen, 
Chiang et al. 2007). The precise role of UvrA2 remains unclear due to the redundancy of the 
multiple UV-damage repair pathways in bacteria. A recent study of P. putida NER proteins 
indicates that UvrA2 is also involved in repair of damaged DNA, a role that becomes evident 
only in the absence of UvrA1 (Tark, Tover et al. 2008). 
In 2005 when we started to work on drUvrA1 and drUvrA2, it became rapidly 
apparent that drUvrA2 was more suitable for structural studies, since drUvrA1 had a strong 
tendency to aggregate. Sofia Caria, a Portuguese Masters’ student purified and crystallised 
drUvrA2 and it took us nearly one year to solve its crystal structure. A construct 
corresponding to residues 81-922 of drUvrA2 was cloned, expressed and purified with a N-
terminal His-tag in the presence of ATP on a Ni-affinity column followed by a SEC step. Two 
crystal forms were obtained by vapour diffusion with reservoir solutions consisting of 17% 
PEG 3000, 0.1M citrate pH 5.2, 1mM TCEP +/- 125mM ammonium sulphate. These 
belonged to the C2 and C2221 space groups and contained respectively three and two 
molecules per asymmetric unit. Diffraction data were collected on ID29 and ID23-1 at the 
ESRF and the structure was initially phased by a three-wavelength multiple-wavelength 
anomalous dispersion (MAD) experiment around the Zn K absorption edge of a single C2 
crystal of drUvrA2. However, high quality experimental electron density was only obtained 
by multi-crystal density modification and averaging using data from both crystal forms, which 
allowed, with the aid of selenomethionine positions obtained from anomalous difference 
fouriers, an almost complete model of the structure of drUvrA2 to be constructed. The C2 and 
C2221 models were refined respectively to 2.3 Å and 3.0 Å resolution with Rfact/Rfree of 
21.9/29.4% and 21.7/29.4% (Table 6).  
In both crystal forms, the functional unit of drUvrA2 is a dimer with two ADP 
molecules bound to each monomer. Fortuitously, each copy of the molecule adopts a different 
conformation, thus providing a view of five distinct monomeric and three dimeric 
conformational states. The drUvrA2 dimer is a saddle-shaped molecule, consisting of a core 
region with two elongated domains protruding from this central core. Each monomer of 
drUvrA2 contains two ABC-type NBDs, an insertion domain (ID) and two zinc-binding 
modules (Figure 24). Such a domain organisation is commonly found in eukaryotic ABC 
proteins (Higgins 1992); prokaryotic ABC proteins in contrast usually possess a single NBD. 
The ID consists of a separate globular domain that exhibits a unique fold, consisting of a core 
helical domain with two anti-parallel β-strands and an additional α-helix inserted between 
two semi-continuous helices. Each NBD consists of two lobes. Lobe 1 the catalytic, RecA-
like subdomain, contains the Walker A motif and consists of two β-sheets flanked by α-
helices. Lobe 2 is an α-helical subdomain and contains the ABC signature sequence. In a 
monomer the two NBDs (NBD-I, NBD-II) form an intramolecular dimer and are arranged in 
a head-to-tail fashion. Zn binding module 2 is inserted into the signature sub-domain of NBD-
II while Zn binding module 3 is inserted into the signature sub-domain of NBD-I. Two ADP 
molecules are bound in composite nucleotide binding pockets formed by the Walker A motif 
of one NBD and the ABC signature sequence of the second. The Walker A motifs, located at 
the N-terminus of helices α1 and α17 are highly conserved in UvrAs and participate in a 
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dense network of hydrogen bonds which support the phosphate groups, while the adenine 
moieties are stabilised by π-stacking interactions. In both binding sites the amino group of the 
conserved lysine (K49 and K536) and the hydroxyl group of the adjacent serine form 
hydrogen bonds to the β-phosphate of the ADP.  
Table 6. Summary of crystal parameters, data collection and refinement statistics for 
drUvrA2. The numbers in parentheses are those for the highest resolution shells.  
Data statistics 
X-ray data Zn-SAD High 
Resolution 
Zn-MAD Se-SAD 
Space group C2221 C2 C2 C2 C2 C2 
Unit cell a = 149.7 
Å, b = 
170.9 Å, c 
= 204.3 Å 
a =269.8 Å, 
b = 110.1 
Å, c = 
101.0 Å, 
β=100.8° 
a = 271.6 Å, b = 110.9 Å, c = 102.7 
Å,  β=101.0° 
a =268.7 Å, 
b = 109.1 
Å, c = 
102.4 Å, 
β=101.0° 
Wavelength (Å) 1.2825  
(pk) 
0.9800 1.2828 
(pk) 
1.2830 
(ip) 
0.9756 
(re) 
0.9793  
(pk) 
Resolution range 
(Å) 
50.0 - 3.0 
(3.2 - 3.0) 
47.3-2.3 
(2.4 - 2.3) 
46.6-2.6 
(2.7- 2.6) 
46.6-2.6 
(2.7- 2.6) 
46.9-2.4 
(2.5-2.4) 
30.0-3.5  
(3.7 - 3.5) 
Rsym (%) 9.7 (54.9) 7.7 (59.2) 5.0 (59.8) 6.3 (80.0) 5.7 (88.7) 10.0 (28.0) 
Unique reflections 50,546 
(7,444) 
123,364 
(12,065) 
84,618 
(8,840) 
84,644 
(8,707) 
75,469 
(8,057) 
36,763 
(5,332) 
<(I)/σ(I)> 11.2 (2.1) 7.1 (1.1) 14.1 (1.5) 12.2 (0.9) 9.1 (0.7) 16.6 (4.8) 
Completeness (%) 96.4 (98.2) 92.1(62.1) 90.0(50.9) 94.1(67.4) 66.1(48.9) 99.8 (100) 
Refinement 
R / Rfree(%) 21.7/29.4 21.9/29.4 
<B> (Å2) 67.5  57.3 
r. m. s. deviations from ideal geometry 
Bond lengths (Å) 0.018 0.014 
Bond angles (o) 1.964 1.536  
Ramachandran plot 
Favoured (%) 
Allowed (%) 
Generously 
allowed  (%) 
Disallowed (%) 
79.7 
19.1 
 
1.0 
0.1 
88.0  
11.1 
 
0.6 
0.2 
 
The two ADP binding sites observed in each monomer of drUvrA2 are not identical. 
Such an asymmetry of nucleotide binding sites in dimeric NBDs has been shown to be 
essential for efficient regulation of protein function (Lamers, Winterwerp et al. 2003; 
Zaitseva, Oswald et al. 2006). An analysis of all available structures of NBDs indicate that a 
number of structural rearrangements occur upon nucleotide binding, which has led to the 
postulation of an induced fit mechanism (Karpowich, Martsinkevich et al. 2001). Notably the 
Q-loop linking the two subdomains of each NBD appears to act as a switch. The conserved 
glutamine residue characteristic of this motif is believed to bind the catalytic magnesium ion 
and/or the nucleophilic water molecule of the ATP hydrolysis reaction (Hopfner and Tainer 
2003). 
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Figure 24: Structure of drUvrA2. (A) Surface and ribbon representation of monomeric 
drUvrA2. The domains are coloured as follows: NBD-I ATP-binding domain (red), NBD-I 
Signature domain (magenta), NBD-II  ATP-binding domain (blue), NBD-II Signature domain 
(cyan) and Insertion domain (ID; green). Zinc ions and ADP molecules are illustrated as 
spheres. (B) Top and side views of the dimeric assemblies of drUvrA2. (C) Superposition of 
the bstUvrA dimer (blue) and the three drUvrA2 dimers observed in our crystal structures 
(C2 AB dimer in red, C2 CC* dimer in green and C2221 AB dimer in yellow), showing the 
high degree of flexibility demonstrated by the Insertion Domains (coloured). The core NBDs 
of the four dimers are shown in grey. (D) Surface representation of drUvrA2 dimer showing 
the regions involved in dimer formation. The interfacing residues are coloured in pale yellow 
(monomer A) and light blue (monomer B). The conserved motifs are highlighted: Walker A 
(red), Walker B (green), signature sequence (orange) and Q-loop (blue). 
A number of observations suggest that in our structures, NBD-II displays a more closed, 
ATP bound-like conformation, than NBD-I. In particular, overlaying the ATP binding sub-
domains of NBD-I and NBD-II of drUvrA2 reveals a rotational movement of ~5° of the 
signature sub-domain relative to the ATP binding sub-domain in NBD-II. In addition, in our 
structures the Q-loops adopt different conformations in the two NBDs. Notably, the conserved 
Gln99 from the Q-loop of the more open NBD-I domain of drUvrA2 points away from the 
bound nucleotide, whereas in NBD-II, the equivalent residue (Gln591) points inwards 
towards the β-phosphate of the ADP. Thus upon ATP binding we expect the signature sub-
domain to move so that the Q-loop can directly interact with the nucleophilic water involved 
in ATP hydrolysis, thereby pulling the entire subdomain, and its associated ID, closer to the 
nucleotide binding pocket (Oswald, Holland et al. 2006). 
The dimer interface is formed in the main by contacts between NBD-I subunits 
(Figure 24B) and the four nucleotide binding sites contained in the dimer are not at the dimer 
interface. In 2008, the crystal structure of Geobacillus stearothermophilus UvrA1 (bstUvrA) 
was reported (Pakotiprapha, Inuzuka et al. 2008). While the crystal structure of drUvrA2 
monomer is very similar to that seen for bstUvrA (rmsd of 1.24Å for 593 aligned Cα atoms), 
on closer inspection, however, there is an interesting difference in the structures of bstUvrA 
and drUvrA2 dimers. In the former, the two IDs contained are well separated (~40 Å apart) 
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and allow unhindered access to regions of the ventral surface of UvrA, which have been 
shown to be involved in the binding of DNA (Croteau, DellaVecchia et al. 2008; 
Pakotiprapha, Inuzuka et al. 2008). In contrast, in the drUvrA2 dimer, the IDs are much closer 
together and the underside of the core is no longer exposed to allow the direct binding of 
DNA. While the two conformations observed are probably stabilised by their respective 
crystal packing, it is clear that UvrA dimers can exhibit conformational variability and can 
adopt ‘ID open’ (seen in the crystal structure of bstUvrA) or ‘ID closed’ (seen in the crystal 
structures of drUvrA2) configurations (Figure 24C). Further evidence of this conformational 
variability is seen when comparing the structures of the three dimers we see in the two crystal 
forms in which we have solved the structure of drUvrA2. In each case the orientation of the 
IDs relative to the dimer core is different and the configuration of the IDs more or less closed. 
Although the nucleotide binding sites in drUvrA2 and bstUvrA are not located at the 
dimer interface, they are, however, adjacent to the structural elements involved in the 
stabilisation of the dimer (Figure 24D). The close proximity between the dimerisation 
interface and the nucleotide binding pockets ensures that the formation of the dimer is tightly 
regulated by the nucleotide binding state of UvrAs. Elongation factor eEF3 also contains two 
NBDs per monomer and in the absence of nucleotide, NBD-II is rotated by 120° away from 
NBD-I in the elongation factor monomers (Andersen, Becker et al. 2006). In the presence of 
ATP the two NDBs adopt the tandem formation seen in nucleotide-bound homodimers of 
MJ0796 (Smith, Karpowich et al. 2002) and Rad50 (Hopfner, Karcher et al. 2000), in 
nucleotide-bound monomers of bstUvrA and in the structures of drUvrA2 monomers. Thus, 
in the ABC protein family nucleotide binding favours the tight association of two NBDs. This 
nucleotide-dependent association of the two NBDs of drUvrA2 into a compact structure most 
likely provides a suitable interface for the head-to-head dimerisation of drUvrA2. In the 
absence of nucleotide it is therefore probable the two NBDs of UvrAs, which are connected 
by a long linker region, adopt an open conformation, as seen for nucleotide-free eEF3. This 
would account for the increased instability of nucleotide-free drUvrA2 we observe in 
solution. In addition, in one of the dimers we observe, the conserved Gln99, located in the Q-
loop, contributes to the stability of the dimer when it is pointing away from the nucleotide 
binding pocket. Flipping of this residue upon ATP binding and hydrolysis (as mentioned 
previously) may act as a switch mechanism directly coupling monomer-dimer transition to 
ATP binding and hydrolysis.  
DNA binding experiments were carried out with drUvrA2. drUvrA2 can bind to both 
undamaged dsDNA and to dsDNA containing a fluorescein-adducted thymine (FldT), a 
known substrate for the UvrABC excinuclease (DellaVecchia, Croteau et al. 2004; Van 
Houten, Croteau et al. 2005). Quantification of the amount of free DNA also reveals that 
drUvrA2 binds preferentially to dsDNA containing a lesion (Figure 25). The location of the 
damage within the oligonucleotide also seems to be important since drUvrA2 binds 
preferentially to duplexed DNA with the FldT-modified base located in the middle of the 32-
mer, suggesting that drUvrA2 requires duplexed DNA on either side of the lesion for stable 
association on the DNA. A surface representation of UvrA dimers reveals a long positively 
charged groove that runs diagonally across the ventral surface of UvrAs (Figure 26), which 
could accommodate a 32-mer dsDNA. Interestingly, in the ‘ID open’ conformation of UvrA 
dimers observed in the bstUvrA structure, this surface is freely accessible to DNA; this is not 
the case in our drUvrA2 structures. Thus, in order for DNA to interact with the ventral surface 
of drUvrA2 dimers the two IDs must either (a) move apart to allow DNA access to this 
surface (i.e. they are not directly involved in DNA binding) or (b) clasp onto the DNA and 
transport it to the ventral surface of the dimer (i.e. the IDs are directly involved in DNA 
binding).  
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Figure 25: (A) EMSAs of drUvrA2 binding to intact and fluorescein-adducted DNA. Prior to 
electrophoresis, increasing amounts of wild-type drUvrA2 (0, 0.25, 1, 2.5 and 10 µM) were 
incubated with 1 µM of intact (orange) or fluorescein-adducted thymine (at position 17 or 29; 
respectively white and yellow) containing dsDNA. (B) The free DNA in the EMSAs (A) was 
quantified, averaged from three measurements in each case and plotted as histograms. (C) 
Surface representation of the ID of drUvrA2 showing the strictly conserved residues in dark 
green and highly conserved residues (≥70% conservation in UvrAs) in pale green. The 
mutated residues are indicated and an orange cylinder indicates the proposed position of the 
bound dsDNA. (D) dsDNA binding activity of wild-type (WT) and mutant drUvrA2s. 
Increasing amounts of drUvrA2 (0, 0.25, 1, 2.5 and 10 µM) were incubated with 1 µM of 
fluorescein-adducted thymine (position 17) containing dsDNA prior to electrophoresis. The 
free dsDNA was quantified, averaged from three measurements in each case and plotted as 
histograms. (E) Histogram illustrating the differential binding of 10 µM WT, ΔID, ΔZn3 and 
K49A mutant drUvrA2 to 1 µM intact (orange) and damaged (white) dsDNA. 
A number of observations suggest that the IDs are directly involved in DNA binding. 
Calculation of the electrostatic surface potential of drUvrA2 and bstUvrA reveals conserved 
positively charged patches on the insides of the IDs and in the case of drUvrA2 also at the tips 
of the IDs. These regions could provide interaction surfaces for negatively charged DNA. 
Moreover, primary sequence analysis of UvrA proteins also reveals that the IDs contain a 
significantly higher number of conserved positively charged and aromatic residues compared 
to the rest of the protein. Also a search for structural homologues of the drUvrA2 ID 
identified a ribosomal protein chain M (Tung, Joseph et al. 2002), which is similar in structure 
to the central helical core of the domain (rmsd of 1.8 Å for 40 aligned Cα atoms). 
Interestingly, ribosomal protein M interacts with duplex RNA and suggests a possible mode 
of how the IDs in UvrAs might interact with DNA. The resulting model of drUvrA2 bound to 
dsDNA (Figure 26) based on this is reminiscent of the MutS-DNA complex (Lamers, Perrakis 
et al. 2000), which also involves a core NBD domain linked to a more flexible DNA-binding 
domain. 
To test whether the IDs are directly involved in DNA binding, we prepared a number 
of point mutants in order to remove positive charges from regions of the IDs that, according 
to our model, could be involved in DNA binding. Two of these regions are located in the 
conserved central helical core of the ID (residues R260, H261, K275 and R277 in helices α8 
and α9), while a third is situated on the helix forming the tip of the domain (residues K244, 
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K245 and K246). This helix is missing in the structure of bstUvrA and is not conserved 
within the UvrA family. For the two mutants, R260E/H261E and K275E/R277E, binding to 
DNA is severely disrupted (Figure 25D), indicating that the central region of the IDs is 
essential for dsDNA binding. The triple mutant (K244E/K245E/K246E) displays a less severe 
phenotype compared to the R260E/H261E and K275E/R277E mutants – its ability to bind to 
dsDNA is nonetheless reduced compared to wild-type drUvrA2, indicating that this region 
may also be playing a role in dsDNA binding. One possibility is that this positively charged 
region allows UvrA to recruit and guide the DNA towards the inside of the IDs. 
Two mutants of drUvrA2: one in which the entire ID was deleted (drUvrA2-ΔID) and 
one in which the C-terminal zinc-finger motif associated was truncated from CXXC–X19–
CXXC to CXXC–X5–CXXC (drUvrA2-ΔZn3) were assayed for their ability to bind dsDNA 
with or without a fluorescein-adduct (Figure 25E). Both mutants exhibited significant binding 
to both types of dsDNA substrates, thus confirming previous studies, which revealed that the 
ID and the C-terminal zinc-finger motif of UvrAs were dispensable for DNA binding 
(Croteau, DellaVecchia et al. 2008; Pakotiprapha, Inuzuka et al. 2008). That drUvrA2-ΔID 
binds dsDNA more efficiently than wild-type drUvrA2 is perhaps counter-intuitive as we also 
show that residues within the ID are crucial for dsDNA binding by intact drUvrA2. However, 
in both our deletion mutants (drUvrA2-ΔID and drUvrA2-ΔZn3), the ventral surface of the 
dimer would be more freely accessible to DNA and our results confirm previous observations 
that the ventral surface of the UvrA dimers is also involved in DNA binding.  
However, unlike wild-type drUvrA2, both our deletion mutants display a complete 
loss in the ability to differentiate between intact and damaged DNA (Figure 25E). This effect 
can be observed principally as a large increase in binding of the deletion mutants to non-
damaged dsDNA compared to wild-type drUvrA2. Removal of the tip of the C-terminal zinc-
finger motif from B. caldotenax UvrA was shown to result in the same dsDNA binding 
profile, suggesting that this region is indeed critical for damage recognition (Croteau, 
DellaVecchia et al. 2006). Our data clearly indicates that efficient recognition of DNA lesions 
requires the presence of both the ID and the C-terminal zinc-finger.  
The process leading to damage recognition is known to be regulated by the nucleotide-
bound state of UvrAs (Thiagalingam and Grossman 1991; Thiagalingam and Grossman 
1993). Both the ID and the C-terminal zinc-finger are inserted within the NBDs. 
Conformational changes associated with nucleotide binding and hydrolysis, such as 
movement of the Q-loop, would thus be transmitted directly to these domains. To further 
investigate the role of nucleotide binding and hydrolysis on damage recognition by drUvrA2, 
we therefore studied the ability of the Walker A lysine mutant K49A to bind to our two 
dsDNA substrates. Again, as with the domain-deletion mutants described above, dsDNA 
binding is retained but the K49A mutant protein exhibits a significantly impaired capacity to 
differentiate between intact and damaged dsDNA (Figure 25E), suggesting that an intact 
ATPase activity is also a requirement for efficient recognition of DNA lesions. 
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Figure 26: Proposed model for DNA binding. (A)-(B) Illustrations of the electrostatic surface 
potential of drUvrA2 (symmetric dimer of C2-Mol B; semi-open conformation of IDs) 
contoured at ±5 kT/e, where red describes a negative and blue a positive potential. The 
modeled DNA is shown in orange. The residues mutated in our study are indicated by arrows. 
(C) Superposition of drUvrA2 ID (blue) and ribosomal protein (pdb: 1m5g) chain M (red) 
bound to RNA (orange). (D) Model of dimeric drUvrA2 bound to dsDNA showing the 
similarity to the crystal structure of MutS bound to mismatched DNA. For both drUvrA2 and 
MutS, one monomer is colored in pale yellow and the other in light blue.  
Our mutational and structural analyses of drUvrA2 unequivocally assign a significant 
new role for the Insertion Domain of UvrAs in DNA binding and damage recognition. Our 
results allowed us to propose an improved model for DNA binding and damage recognition 
by UvrAs and represent a key contribution to our understanding of the initial steps in bacterial 
NER. They also pave the way for further structure-guided experiments to further dissect the 
detailed molecular mechanisms of UvrA action. This work was published in Structure in 2009 
(Timmins, Gordon et al. 2009). 
  2.2. UvrA1, UvrB and UvrC proteins 
 The UvrB gene was also cloned and successfully expressed in E. coli by 
Protein’eXpert. The protein was highly soluble and could be purified in large amounts. At 
ESRF, two Masters’ students (S. Caria and T. Johansson) under my supervision and a post-
doctoral fellow (O. Sleator) worked on the crystallisation of UvrB alone and in complex with 
DNA, but no crystals were obtained. In 2008, T. Klar, a post-doctoral fellow was recruited to 
study the UvrA-UvrB interaction. T. Klar optimised the expression and purification protocol 
for UvrA1 and also cloned, expressed and purified the domains of UvrA1 and UvrB expected 
to be involved in protein-protein interactions. But unlike their homologues from G. 
stearothermophilus or E. coli, D. radiodurans UvrA (both UvrA1 and UvrA2) and UvrB 
proteins do not form a stable complex suitable for structural studies.  
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 In 2010, together with Samira Acajjaoui, the laboratory technician from the ESRF 
Structural Biology Group and Mats Ökvist, a scientist in the group, I started to work on D. 
radiodurans UvrC, which according to Protein’eXpert’s work was mostly insoluble. The full-
length gene and a construct corresponding to the C-terminal domain (residues 366-617) were 
cloned into a bacterial expression vector, expressed in E. coli and purified to homogeneity. 
The intact UvrC required high salt for stability. In such conditions, it appears to exist in the 
form of both dimers and monomers in solution as evaluated by SEC, MALLS and SAXS. So 
far, no crystals were obtained for UvrC. The C-terminal domain was purified in large amounts 
and crystals were obtained using the EMBL crystallisation robot in conditions containing 25% 
PEG 5,000 MME or 25% PEG 3,350 and 0.1M Bis-Tris pH6.5. Diffraction data was collected 
on these thin plates on ID14-4 to a maximum resolution of 1.8 Å (Table 7).  
Table 7 Crystallographic data and refinement statistics for UvrC-Cterm. Values in 
parentheses are for highest resolution shell. 
 
Data statistics UvrC-Cterm 
Space group P21 
Unit cell (Å/º) a=50.4, b=40.8, c=59.6, 
β=90º 
Resolution range 40.81-1.80 (1.90-1.80) 
Rsym (%) 6.5 (31.0) 
<I>/<σI> 13.7 (4.0) 
Completeness 99.6 (98.2) 
Twin fraction  0.3 
Refinement  
Unique reflections 21,462 
Rfact/Rfree 16.6/20.6 
Mol/asu 1 
Average B-factor 25.4 
Rms deviations 
           Bonds (Å) 
           Angles (º) 
 
0.020 
1.846 
 
 The crystal structure was solved by molecular replacement using Phaser and the two 
individual domains composing the crystal structure of the C-terminal region of T. maritima 
UvrC (Karakas, Truglio et al. 2007) as search models. The C-terminal region of D. 
radiodurans UvrC is composed of the 5’ RNase H endonuclease domain and two Helix-
hairpin-Helix (HhH) motifs forming a (HhH)2 domain (Figure 27). The structures of the 
individual domains are very similar to those of T. maritima UvrC, but the relative orientation 
of the HhH motifs with respect to the endonuclease domain is quite different. Preliminary 
SAXS studies on this construct also indicate that the conformation observed in the crystals is 
different from that adopted in solution, where a more elongated arrangement appears to be 
seen. New constructs of UvrC are now in preparation to obtain more structural information 
regarding the central and N-terminal region of UvrC. A manuscript describing these results is 
in preparation (Ökvist et al, 2012). 
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Figure 27: (A) Example of the 2Fo-Fc electron density maps (contoured at 1σ) obtained for 
UvrC-Cterm. (B) Crystal structure of UvrC-Cterm. It is composed of two domains: a RNase 
H endonuclease domain and two HhH motifs forming a (HhH)2 domain. (C) Overlay of the C-
terminal regions of D. radiodurans UvrC (blue) and T. maritima UvrC (green). 
  2.3. UvrD Helicase 
 In 2008, Samira Acajjaoui started to work under my supervision on the UvrD helicase 
from D. radiodurans, an essential DNA helicase involved in many DNA repair pathways. In 
2010, Meike Stelter, a post-doctoral fellow at ESRF (and now working with me at IBS) joined 
the UvrD project.  
Many biological processes, such as DNA replication, transcription, recombination or 
repair, require access to the genetic information hidden within the duplex DNA of the genome 
and for this purpose dsDNA needs to be transiently unwound. A diverse set of enzymes, 
known as DNA helicases, is responsible for catalysing this process (Tuteja and Tuteja 2004b; 
Tuteja and Tuteja 2004a). DNA helicases are ubiquitous enzymes and many different 
helicases are found in a single cell due to the diversity of structures adopted by duplexed 
DNA. Helicases are a subset of the translocase enzyme family that share a number of 
conserved signature motifs responsible for either NTP binding and hydrolysis, DNA binding 
or for coupling these two processes. Based on primary structure analyses and extensive 
biochemical studies, six superfamilies of helicases have so far been described, each of which 
possesses a different set of conserved signature motifs (Gorbalenya and Koonin 1993; 
Singleton, Dillingham et al. 2007). Three of these superfamilies (SF1, SF2 and SF6) have 
been further classified according to their directionality 3’-5’ (type A) or 5’-3’ (type B) 
(Singleton, Dillingham et al. 2007). 
UvrD is a SF1A helicase (Gorbalenya and Koonin 1993) that plays important 
functions in DNA replication (Bruand and Ehrlich 2000), recombinational repair (Arthur and 
Lloyd 1980; Veaute, Delmas et al. 2005; Bentchikou, Servant et al. 2010), methyl-directed 
mismatch repair (Matson and Robertson 2006) and nucleotide excision repair (Caron, 
Kushner et al. 1985). UvrD consists of two RecA-like domains (1A and 2A) that are 
responsible for nucleotide binding and hydrolysis and two additional domains (1B and 2B) 
that are involved in dsDNA binding. The crystal structures of several UvrD-like helicases in 
complex with DNA (Korolev, Hsieh et al. 1997; Velankar, Soultanas et al. 1999; Lee and 
Yang 2006), together with kinetic and single-particle studies (Ali and Lohman 1997; 
Dillingham, Wigley et al. 2002; Dessinges, Lionnet et al. 2004; Fischer, Maluf et al. 2004) led 
to the proposal of a combined wrench-and-inchworm mechanism for DNA unwinding (Figure 
28A) (Lee and Yang 2006; Yang 2010). In this model, a rotational movement regulated by 
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ATP binding and hydrolysis acting as the ‘engine’ is combined with alternate tight and loose 
interactions at four protein-DNA contact points to produce a highly coordinated unidirectional 
movement along DNA. An alternative mode of unwinding, known as strand-displacement, 
has also been reported, notably in the absence of domain 2B and duplex DNA binding 
(Cheng, Brendza et al. 2002; Lee and Yang 2006), in which movement of ssDNA is 
deregulated due to reduced contacts with dsDNA.  
In D. radiodurans, unlike in E. coli, UvrD is involved in diverse DNA repair pathways 
(Bentchikou, Servant et al. 2010). In particular, UvrD has been shown to play a central role in 
double-strand break (DSB) repair and reconstitution of the genome following chromosome 
fractionation (Bentchikou, Servant et al. 2010). In E. coli, the RecQ, RecD and Helicase IV 
enzymes participate in DSB repair while in D. radiodurans, these three helicases have been 
shown to be dispensable (Bentchikou, Servant et al. 2010). Interestingly, Helicase IV from D. 
radiodurans exhibits 5’-3’ activity, while its E. coli homologue unwinds DNA with 3’-5’ 
polarity (Wood and Matson 1987; Cao and Julin 2009), indicating that the involvement, 
importance and polarity of a helicase in a given cellular pathway are not conserved from one 
bacterium to another. 
Between 2009 and 2011, we determined the crystal structures of D. radiodurans UvrD 
(drUvrD) in complex with 3’-tailed dsDNA in apo- and AMP-PNP bound states and 
characterised its in vitro DNA unwinding activity. The manuscript describing this work has 
been submitted to Plos One (Acajjaoui et al, 2012).  
 
Figure 28: (A) Schematic representation of the wrench-and-inchworm unwinding mechanism, 
indicating the four critical protein-DNA contact points: the GIG motif interacts with dsDNA 
(1), the β-hairpin motif with the ss-dsDNA junction (2), motif III with the ssDNA (3) and the 
ssDNA gateway with the exiting ssDNA (4). (B) Schematic representation of the domain 
structures of drUvrDFL and drUvrD∆C. (C) Illustration of the DNA oligonucleotides used for 
crystallisation of the ternary complexes, containing either drUvrDFL or drUvrD∆C bound to 
3’-tailed dsDNA and AMPPN. Examples of crystals obtained for each of these complexes are 
shown on the right. 
Full-length drUvrD (drUvrDFL) and a truncated drUvrD (drUvrD∆C), missing residues 
666-745 (Figure 28B), were cloned into a bacterial expression vector and expressed in E. coli. 
The proteins were purified on a Ni-affinity column followed by a heparin-affinity 
chromatography, yielding milligrams of pure, homogeneous sample. EMSAs were used to 
identify the optimal DNA substrates (in terms of length of the double- and single-stranded 
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regions) for co-crystallisation with UvrD, using the work on E. coli UvrD as a guide (Lee and 
Yang 2006). The first crystals were obtained in 2009 with the truncated drUvrD (drUvrD∆C) 
in complex with an 18 base-pair dsDNA oligonucleotide with 7 nucleotide extensions at the 
3’ end and 1 mM AMP-PNP (Figure 28C) using the hanging-drop vapour diffusion method. 
Two crystal forms were obtained: Form I crystals appeared rapidly (<1day) in 20% PEG 
3,350, 0.1M Bis-Tris Propane pH 7.0 and 0.2M Na-Nitrate, while Form II crystals appeared 
after at least one week in 22% PEG 3,350, 0.1M Bis-Tris Propane pH 7.5 and 0.1M Na-
Fluoride. At a later stage of the project, in 2010, we used our experience with drUvrD∆C to 
crystallise the full-length drUvrD with a 21 base-pair dsDNA oligonucleotide with 7 
nucleotide extensions at the 3’ end. At first, very small, thin plates were obtained in 
conditions similar to those used for crystals of Form I, and these crystals were used for 
seeding experiments in order to grow crystals to a suitable size and quality for data collection 
(Figure 28C).  Diffraction data were collected at the ESRF on beamlines ID14-2, ID14-4 and 
ID23-1 (Table 8). The structure of drUvrD∆C-For25/Rev25 form I was solved by molecular 
replacement using the gsPcrA helicase as a search model (PDB: 3PJR). After several rounds 
of substantial rebuilding of the protein chains, the DNA could be built and the AMPPNP 
molecules docked into the electron density. Subsequently, this model was used to solve the 
structures of drUvrD∆C-For25/Rev25 form II and drUvrDFL-For28/Rev28 by molecular 
replacement with Phaser.  
Table 8 Crystallographic data collection and refinement statistics. Values in parentheses are 
for highest resolution shell. 
 
Dataset drUvrDFL drUvrD∆C form I drUvrD∆C form II 
Data collection    
Protein drUvrDFL drUvrD∆C drUvrD∆C 
DNA For28/Rev28 For25/Rev25 For25/Rev25 
Nucleotide AMPPNP AMPPNP AMPPNP 
Space group P21 P212121 P21 
Cell dimensions   
    a, b, c (Å) 
    α, β, γ  (°) 
 
71.58, 390.58, 71.65  
90.00, 106.00, 90.00 
 
67.57, 67.45, 386.04 
90.00, 90.00, 90.00 
 
68.49, 89.79, 293.80 
90.00, 89.97, 90.00 
Beamline ESRF ID14-4 ESRF ID14-2 ESRF ID23-1 
Resolution (Å) 46.15 – 4.00  
(4.22– 4.00) 
47.40 – 2.55  
(2.69 – 2.55) 
47.63 – 3.00  
(3.16 – 3.00) 
Rmerge (%) 10.6 (65.8) 7.1 (59.2) 6.4 (32.0) 
<(I)/σ(I)> 10.1 (2.3) 20.4 (3.6) 6.5 (1.9) 
Completeness (%) 99.6 (99.5) 100.0 (100.0) 89.0 (86.5) 
Refinement    
N° of  reflections  30,051 56,088 59,507 
Rfact/Rfree (%) 24.6/27.1 21.1/26.6 22.8/28.8 
Mol/asu 4 chains UvrD 
2 chains dsDNA 
2 chains UvrD 
1 chains dsDNA 
4 chains UvrD 
2 chain dsDNA 
Ligands 4 AMP-PNP 2 AMP-PNP 2 AMP-PNP 
Average B-factor (Å2) 
    Protein 
    DNA 
    AMPPNP 
    Solvent 
 
203.0 
256.8 
168.8 
N/A 
 
63.9 
163.9 
29.7 
38.5 
 
102.2 
132.0 
84.6 
84.3 
Rms deviations 
    Bonds (Å) 
    Angles (°) 
 
0.006 
1.1 
 
0.017 
1.7 
 
0.012 
1.5 
 55 
Crystals of drUvrDFL-For28/Rev28 diffracted X-rays to 4.0 Å (Table 8). Despite being 
present in the crystallised protein, residues 663-745 corresponding to the variable C-terminal 
region could not be traced in the electron density map, confirming that this region is 
particularly flexible (Manelyte, Guy et al. 2009). Higher resolution diffraction was obtained 
from crystals containing drUvrD∆C. Crystals of form I diffracted to 2.5 Å, while crystals of 
form II diffracted to a maximum resolution of 3.0 Å. In all structures, each drUvrD monomer 
is bound to the ds-ssDNA junction at either end of the DNA duplex, thus forming an 
assembly of one DNA duplex with two UvrD monomers (Figure 29B). As in previous 
structures of UvrD-like helicases (Korolev, Hsieh et al. 1997; Velankar, Soultanas et al. 1999; 
Lee and Yang 2006), there are no direct contacts between the two UvrD monomers loaded on 
a given DNA duplex. In the structures of drUvrDFL and drUvrD∆C form I, each of the protein 
monomers contains one bound AMPPNP molecule, whereas in drUvrD∆C form II each 
assembly is composed of a DNA duplex with an AMPPNP-bound UvrD on one end and an 
apo-UvrD on the other.  
 
Figure 29: (A) Crystal structure of one monomer of drUvrD∆C bound to duplex DNA with a 
single-stranded extension at the 3’-end. The translocating strand is coloured black and the 
complementary strand is coloured red. The domains of drUvrD∆C are shown in ribbon and 
are coloured green (1A), beige (1B), orange (2A) and blue (2B). AMPPNP is shown in sticks. 
(B) Ribbon illustrations of AMPPNP-bound drUvrDFL, AMPPNP-bound drUvrD∆C form I and 
the mixed AMPPNP-bound (red) and apo- (blue) drUvrD∆C form II. The DNA and AMPPNP 
are shown in sticks. (C) Overlay of chains A (red) of drUvrDFL and apo-drUvrD∆C form II, 
illustrating the large spiral movement of chains B coloured respectively yellow, grey and 
blue. The DNA is shown as an orange ribbon.  
drUvrD displays 36% sequence identity with E. coli Rep (ecRep) and UvrD (ecUvrD) 
helicases and 42% sequence identity with G. stearothermophilus PcrA (gsPcrA) helicase, all 
of which are members of the SF1A helicase family. The overall structures of the drUvrD 
monomers are very similar to those observed in the closed conformation of gsPcrA-DNA and 
ecUvrD-DNA complexes and consist of four domains: 1A, 1B, 2A and 2B (Figure 29A). 
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When present, AMPPNP is bound at the interface between domains 1A and 2A. ssDNA 
interacts with all four domains, a majority of contacts being with domain 2A, and interactions 
with dsDNA involve mainly domain 2B. A close look at domain interfaces reveals that most 
of the non-conserved residues are found in these areas. The nature of contacts and interface 
areas between domains 1A/1B and 1B/2B are indeed very different in ec- and drUvrD. In 
drUvrD, these interfaces are significantly smaller than in ecUvrD and involve many more 
ionic interactions. Such differences may impart increased plasticity and flexibility to drUvrD, 
but may also increase its sensitivity to stress-related changes in its local environment (e.g. pH, 
temperature, salt concentration). 
The relative orientation of the components of the protein-DNA assembly observed in 
drUvrD∆C form II is similar to those observed in previous structures of SF1A helicases. Our 
structures of drUvrDFL and drUvrD∆C form I, however, provide us with two new snapshots of 
the unwinding process. In both of these cases the two drUvrD protomers are located on the 
same side of the DNA duplex and induce a major bend in the DNA. In drUvrD∆C, hydrolysis 
of one of the AMPPNP molecules and release of the nucleotide leads to the formation of 
crystal form II in which the apo molecule has rotated 125° around the DNA with respect to 
the position of drUvrDFL or 105° with respect to crystal form I (Figure 29B and C), resulting 
in an assembly with one drUvrD on either side of the DNA duplex. In this assembly, the apo-
drUvrD∆C molecule has unwound the 3’-single-stranded DNA extension and maintains the 
ssDNA in a bent orientation with respect to the DNA duplex axis. As a result, the DNA 
duplex itself shows a reduced helical twist and reduced bending. Because of the helical nature 
of nucleic acids, helicases are expected to translocate along DNA in a spiral movement. For 
the first time, our structures provide three snapshots of this large-scale, ATP-dependent spiral 
movement. This spiral trajectory results from the positioning of the helicase at an angle 
relative to the dsDNA axis and from a combination of rotational and translational movements, 
known as the wrench-and-inchworm mechanism.  
Detailed analysis of the ss- and dsDNA binding in our different structures clearly 
indicates that drUvrD, like ecUvrD, utilises the wrench-and-inchworm mechanism for 
unwinding DNA. In drUvrD∆C form I, four nucleotides (nt21-24) are tightly bound in the 
ssDNA-binding pocket (Figure 30A and B). The terminal nucleotide (nt25) has already exited 
the helicase and is no longer visible in the electron density maps. Nucleotides 21 and 22 
interact with Arg362 and Asn364 and stack against Phe263 that interferes with the regular 
stacking of the ssDNA bases and forces nucleotides 23 and 24 to adopt an orientation 
orthogonal to nucleotides 21 and 22. Nucleotide 24 is stabilised in this conformation by π-
stacking of the base between Arg264 and Phe196 and of the deoxyribose ring against Phe65. 
These residues are in turn stabilised by a series of stacking interactions involving notably 
Tyr261 and His93. In the AMPPNP-bound molecule of drUvrD∆C form II, nucleotides 20 to 
23 are bound in the binding pocket, indicating that drUvrD has translocated along the ssDNA 
by one nucleotide compared to form I (Figure 30A and B) and as a result both nucleotides 24 
and 25 have become untraceable. As in ecUvrD, the apo-drUvrD∆C observed in crystal form 
II, reveals a fifth nucleotide in the ssDNA binding pocket (Figure 30A and B). Nucleotides 19 
to 23 are now visible and sliding of drUvrD along the DNA has positioned nucleotides 19 and 
20 in the first two binding sites and nucleotides 21 and 22 in the subsequent sites. As a result, 
nucleotide 23 is now trapped on its way out. To allow the terminal nucleotide to exit, Phe196, 
Phe65 and His93 have moved out of the way and the α24-α25 linker that interacts via Ser546 
with the terminal nucleotide in the AMPPNP–bound forms, has maintained its grip on the 3’-
end of the ssDNA and pulled it through the opened gateway driven by the rotation of domain 
2B. Nucleotides 21 and 22 are now stabilised in their new binding sites by interactions with 
Tyr390 and Arg392 from motif IVb. 
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Figure 30: (A) Schematic diagram illustrating the translocation of the different forms of 
drUvrD∆C along the ssDNA. The ssDNA nucleotides are illustrated as black bars and are 
numbered as in the crystal structures. An oval shape representing drUvrD covers the 
nucleotides bound in the ssDNA binding pocket. (B) Surface representation of the ssDNA 
binding pockets of these three forms of drUvrD∆C bound to ssDNA (orange sticks). The 
important residues are labelled and the bases are numbered as in (A). (C) Binding of 
drUvrD∆C to dsDNA in form I, form II with AMPPNP bound and in the apo-form of form II. 
The dsDNA is illustrated in sticks with the translocated strand in grey. Domains of drUvrD 
are coloured as in Figure 29A. The helices belonging to the HLH motifs and the β-hairpin 
structure (orange) are shown and labeled according to the secondary structure succession. 
The positively charged residues in contact with dsDNA are illustrated in sticks and the GIG 
motif is indicated. The number of base-pairs formed between the ss-dsDNA junction and the 
contact point with the drUvrD GIG motif is shown to the left of each panel. This number 
differs significantly between the two crystal forms.  
Similarly the dsDNA binding is affected by the nucleotide-bound state of drUvrD. 
Interactions between drUvrD and dsDNA involve four contact points: one helix-loop-helix 
(HLH) motif from domain 1B (α5-α6), two of the three HLH motifs from domain 2B (α17-
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α18 and α19-α20) and the β-hairpin motif (β13-β14) from domain 2A (Figure 30C). In the 
AMPPNP-bound structures, three of these four sites are in contact with dsDNA, two of them 
are in common and the third differs between the two forms. In both forms, Arg142 from the 
α5-α6 HLH motif interacts with the unpaired nt19 at the ss-dsDNA junction and the α17-α18 
HLH motif containing the conserved GIG motif interacts extensively with nt9-12 in form I 
and nt7-10 in form II. In form I, the third binding site involves Arg459 from the α19-α20 
HLH motif, which interacts with the deoxyribose ring of nt13 (opposite strand) in the minor 
groove of the DNA duplex, while in form II Phe633 from the β-hairpin motif stacks against 
the first base-pair (nt1=nt18) of the duplex (Figure 30C). This interaction pushes out nt19 thus 
forming a bulge in the DNA. In the absence of nucleotide, however, only two of these 
contacts remain: the GIG sequence in the α17-α18 HLH motif interacts with nt7-10 and 
Phe633 from the β-hairpin motif stacks against the first base-pair. 
Although the details of the protein-DNA contacts are not strictly identical in the 
structures of drUvrD, ecUvrD and gsPcrA, taken together, our observations suggest that the 
molecular mechanisms underlying DNA unwinding are highly conserved within the SF1A 
helicase superfamily. During ATP-binding-induced domain closing, binding to duplexed 
DNA (contact 1, see Figure 28A) and ssDNA (contacts 3 and 4) are tight, while contact with 
the ss-dsDNA junction (contact 2) is loose allowing UvrD to translocate along the duplex. 
This leads to the unwinding of one nucleotide that forms a bulge at the ss-dsDNA junction. 
Conversely, during ADP and Pi release, domain rotations open drUvrD’s ssDNA gateway 
(contact 4) to allow the ssDNA to exit the helicase. This is achieved through contacts with the 
ssDNA (contact 3) that remain tight throughout the process allowing to pull the ssDNA 
through the gateway and straighten the bulged out nucleotide. During this step, contacts with 
the DNA duplex are maintained and the β-hairpin (contact 2) stacks against the first base-pair 
and now acts as a solid separation pin to efficiently unwind the dsDNA.  
To better understand how a structurally and mechanistically conserved protein such as 
UvrD may be involved in diverse repair pathways in different species, we investigated 
drUvrD’s catalytic activities in vitro. As other SF1A helicases, drUvrD displays a clear DNA-
stimulated ATPase activity. Analysis of the ATPase data measured on drUvrDFL and 
drUvrD∆C allowed us to determine their apparent turnover rates (Kcat) for ATP hydrolysis, 
along with their Km for ATP and their KssDNA (corresponding to the concentration of ssDNA 
required for half-maximal ATPase rate). The values obtained are in agreement with those 
measured for wild-type and a C-terminally truncated form of ecUvrD (Matson and George 
1987; Manelyte, Guy et al. 2009).  
We then examined the helicase activity of drUvrD on blunt, 3’-tailed, 5’-tailed and 
both 3’- and 5’-tailed dsDNA (Figure 31). Unexpectedly, our data revealed that drUvrD was 
most efficient at unwinding dsDNA oligonucleotides containing 5’-extended single-stranded 
regions. The lowest activities were observed for 3’-extended and blunt dsDNA, while the 
highest activity was measured with duplexes with extensions at both ends. Such a DNA 
would provide two entry points for the helicase, which may explain the high helicase activity 
observed with this substrate. Directionality of SF1 helicases is believed to be determined by 
preferential binding to either a 3’- or a 5’-single-stranded overhang, which acts as the entry 
point for the helicase (Singleton, Dillingham et al. 2007). We carried out fluorescence 
anisotropy measurements to evaluate the affinity of drUvrD for either 3’- or 5’-tailed dsDNA 
(Figure 31). drUvrD binds to both of these substrates, but shows a 2-fold preference for 5’-
extended dsDNA, which may in part explain its higher 5’-3’ helicase activity. 
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Figure 31: (A) Helicase activity of 0-1.5 µM drUvrDFL and drUvrD∆C on 1 µM blunt, 3’-, 5’- 
and 3’- and 5’-extended dsDNA oligonucleotides. The star indicates the position of the 5’-
fluorescein label on the DNA. The gels (left panel) were scanned, the amount of duplexed and 
single-stranded DNA was quantified and the fraction of unwound DNA was plotted against 
the amount of helicase (right panel). (B) Fluorescence anisotropy measurements of drUvrDFL 
binding to 3’- (blue) and 5’- (red) extended dsDNA oligonucleotides. The estimated Kd values 
for each DNA substrate are shown.  
Our and previous structures of UvrD helicases reveal the detailed mechanisms by 
which they unwind DNA in the 3’-5’ direction. There are currently two models that could 
explain how their directionality may be reversed: (i) in model 1, the contact points between 
helicase and DNA remain unchanged, but the orientation of the bound DNA is reversed; (ii) 
in model 2, DNA is bound in the same orientation but the order of alternating tight and loose 
contacts between helicase and DNA is altered. So far, the high resolution crystal structure of 
the SF1B helicase, D. radiodurans RecD2 (drRecD2) in complex with ssDNA (Saikrishnan, 
Powell et al. 2009), suggests that 5’-3’ translocation is achieved according to the second 
model. To determine which of these models explains the 5’-3’ helicase activity of drUvrD, we 
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mutated residues identified in ecUvrD as being essential for 3’-5’ unwinding using the 
wrench-and-inchworm mechanism and tested the DNA binding and helicase activities of 
these mutants.  
DNA binding was assessed using EMSA (Figure 32). In such an assay a similar 
fraction of 5’- and 3’-extended DNA was bound by wild-type drUvrDFL. Mutating each of the 
glycines from the GIG motif individually to threonine (G424T or G426T) did not 
significantly affect dsDNA binding, however the double mutant (G424T/G426T) showed a 
near 50% reduction in binding to duplex DNA. No difference was observed between the 5’- 
and 3’-extended DNA, indicating that the interactions between drUvrD and dsDNA are the 
same for both DNA substrates. Deletion of the β-hairpin structure, which is known to act as a 
separation pin and is essential for UvrD’s helicase activity, did not interfere with DNA 
binding. Finally, mutation of Ser546 (S546A) involved in the ssDNA gateway did not affect 
DNA binding. These mutations had a much more dramatic effect on the helicase activity of 
drUvrDFL (Figure 32). Deletion of the β-hairpin dramatically reduced DNA unwinding of 
both 3’- and 5’-extended substrates. The S546A mutant showed clearly reduced activity on 
5’-extended DNA only. Mutations in the GIG motif led to reduced activity towards 5’-
extended DNA and increased activity towards 3’-extended DNA, resulting in a helicase with 
reversed polarity. Our mutational study clearly shows that irrespective of the DNA substrate, 
dsDNA binding occurs through the GIG motif in domain 2B and DNA unwinding requires an 
intact β-hairpin, indicating that its role as a separation pin is conserved for both 3’- and 5’-
extended DNA. drUvrD thus utilises the same wrench-and-inchworm mechanism to unwind 
DNA in both directions, albeit with higher efficiency in the 5’-3’ direction. In the case of 
drUvrD, reversed polarity is therefore achieved by binding the DNA in the opposite 
orientation.  
 
Figure 32: (A) DNA binding activity of 4 µM wild-type (WT) and mutant drUvrDFL on 1 µM 
3’- (white) and 5’- (grey) extended dsDNA. (B) Helicase activity of 0.4 µM wild-type (WT) 
and mutant drUvrDFL on 1 µM 3’- (white) and 5’- (grey) extended dsDNA. The plotted values 
are the average of at least three independent experiments. Standard deviations are shown as 
vertical bars.  
Despite being structurally and mechanistically conserved with ecUvrD and gsPcrA, to 
our surprise, our assays revealed that drUvrD possesses a robust 5’-3’ helicase activity and 
only a weak 3’-5’ activity. This is consistent with its preferential binding to 5’ extended 
DNA, which could in part explain its higher 5’-3’ helicase activity. Most members of the 
SF1A family show a clear 3’-5’ polarity, but there are, however, several examples, notably in 
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gram-positive bacteria, of enzymes that show bidirectional helicase activity (Soultanas, 
Dillingham et al. 1999; Chang, Naqvi et al. 2002; Naqvi, Tinsley et al. 2003; Constantinesco, 
Forterre et al. 2004; An, Tang et al. 2005). This provides further evidence that UvrD proteins 
vary both in terms of substrate specificity and helicase polarity. A structural comparison of 
the ssDNA binding pockets of ec- and drUvrD indeed reveals substantial differences, 
particularly on the side lined by residues from domain 2B, where the conformation and the 
nature of the residues differ significantly. In drUvrD, the binding pocket forms a positively 
charged channel that guides the ssDNA towards the exit, while in ecUvrD, the pocket is much 
more open. The residues lining the ssDNA binding pocket and gateway may therefore be 
determinant in defining the preferred polarity of a given helicase. This region consisting 
largely of the linker between domains 2B and 2A (residues 540-550 in drUvrD) is poorly 
conserved in SF1A helicases and could account for the observed variations in substrate 
specificity. This hypothesis is supported by our S546A mutant, which displays reduced 
activity on 5’-extended DNA and not on 3’-tailed DNA.  
drUvrD’s ability to unwind DNA duplexes in both directions may reflect its 
implication in diverse DNA repair pathways in vivo. In E. coli, recombinational repair has 
been proposed to involve the 3’-5’ helicases RecQ and Helicase IV and the 5’-3’ helicase 
RecD, while D. radiodurans cells missing these genes show wild-type radioresistance and 
DNA repair capacity (Cao and Julin 2009; Bentchikou, Servant et al. 2010). In contrast, 
inactivation of drUvrD leads to a significant increase in the sensitivity of cells to γ-irradiation. 
This phenotype is further enhanced in cells in which both uvrD and recD2 genes have been 
disrupted, suggesting that the 5’-3’ helicase, drRecD2, may in part back-up drUvrD’s 
function. While further studies will be needed to decipher the detailed molecular mechanisms 
that regulate the bipolar helicase activity of drUvrD, these observations suggest that in vivo 
both helicase activities of drUvrD are needed. drUvrD may be able to switch from a highly 
coordinated 5’-3’ helicase to a processive 3’-5’ helicase in response to external stresses, 
changes in its environment, or upon interactions with pathway-specific protein partners such 
as MutL(Matson and Robertson 2006)(Matson and Robertson 2006) or UvrAB. 
 3. Base excision repair 
 Since 2003, the ESRF Structural Biology Group has been collaborating with the 
Norwegian Structural Biology Centre (NorStruct), a national research and service centre 
located in Tromsø (Norway). Two scientists from NorStruct, Ingar Leiros and Elin Moe, led 
by Arne Smalås, have been studying the Base Excision Repair (BER) enzymes of several 
bacterial species including those of D. radiodurans. I. Leiros was a post-doctoral fellow at 
ESRF from 2002 to 2005, while E. Moe was a regular visitor of the ESRF laboratory between 
2003 and 2010. During this time, E. Moe cloned the 13 predicted DNA glycosylases encoded 
by the D. radiodurans genome and managed to express and purify a large majority of them  
(Table 9). So far, together with her co-workers, E. Moe has solved the structures of five of 
these, three of which have been published (Leiros, Moe et al. 2005; Moe, Leiros et al. 2006; 
Moe, Hall et al. 2012). 
 From 2006 onwards, I became more involved in E. Moe’s projects and was her 
principal contact at the ESRF. In 2007, E. Moe and I submitted a grant proposal to the 
Norwegian Research council, entitled: ‘Functional and structural biology studies of DNA 
repair proteins from the radiation resistant bacterium Deinococcus radiodurans’. This project 
was successful and we obtained funding for a PhD student (Aili Sarre), who started in 2008 
under the supervision of E. Moe in Tromsø and myself during her regular visits to Grenoble. 
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Table 9: Status of the cloning, expression, purification, crystallisation and structure 
determination of D. radiodurans DNA glycosylases. 
Protein Code Cloned Expressed Purified Crystallised Structure determined 
UNG DR0689  X X X X X 
MUG DR0715 X X X X X 
TMUDG DR1751 X X (X)
 
  
Hypothetical 
UDGs 
DR0022 
DR1663 
X 
X 
X 
X 
X 
X   
AlkA DR2074 DR2584 
X 
X 
X 
X 
(X) 
X 
 
X 
 
X 
EndoIII 
DR2438 
DR0289 
DR0928 
X 
X 
X 
X 
X 
X 
X 
X 
X
 
X 
 
X 
X 
 
X 
MutM DR0493 X X X   
MutY DR2285 X (X)    
MutT DR0261 X X (X)
 
  
  
 A. Sarre’s project focuses on the study of D. radiodurans’ Endonuclease III enzymes. 
D. radiodurans possesses an expanded repertoire of BER enzymes: for example its genome 
encodes two 3-methyladenine DNA glycosylases (AlkA) and three Endonuclease III enzymes 
(EndoIII), while most bacteria only possess one copy of each of these essential BER enzymes.  
 
Figure 33: (A)-(B) Ribbon illustrations of the crystal structures of D. radiodurans 
Endonuclease III-1 (A) and ΔN76-Endonuclease III-3 (B). (C) Homology model of D. 
radiodurans Endonuclease III-2. The structures are coloured in rainbow with the N-terminus 
being blue and the C-terminus red. The helices are numbered in the case of EndoIII-1. Active 
site and DNA binding residues are shown in sticks. 
  The BER pathway is responsible for repair of DNA bases damaged by deamination, 
oxidation and alkylation. The pathway is initiated by DNA glycosylases, which recognise the 
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damaged bases and remove them by hydrolysing the N-glycosidic bond between the base and 
the sugar phosphate backbone and generates an abasic site. The after base removal process are 
performed by apurinic (AP) endonucleases, DNA polymerases and DNA ligases. Some of the 
DNA glycosylases are bi-functional and contain an AP-lyase activity in addition to their N-
glycosidic activity, and are not dependent upon the lyase activity of DNA polymerase in order 
to complete the repair. 
Table 10: Data and refinement statistics of D. radiodurans EndoIII-1 and ΔN76-EndoIII-3 
structures. Values in parentheses are for the highest resolution shell. 
Data collection  EndoIII-1 ΔN76-EndoIII-3 
Space group C2 C2 
Cell dimensions (Å/º) a=181.50, 
b=38.56, c=37.11, 
β=89.4 
a=91.24, b=40.21, 
c=72.15, β=102.3 
Resolution (Å) 19.5-1.95 (2.00-
1.95) 
50-1.31 (1.34-
1.31) 
Rmerge (%) 5.8 (28.7) 5.8 (30.2) 
Unique reflections 18638 61009 
Completeness (%) 98.7 (88.7) 98.2% (90.2%) 
Nº mol/asu 1 1 
Refinement    
Rfactor/ Rfree (%) 17.5/23.3 13.5/16.7 
No. atoms 2016 2313 
R.m.s. deviations   
    Bond lengths (Å) 0.015 0.023  
    Bond angles (º) 1.301 1.985 
 
 EndoIII is a bifunctional enzyme that recognises oxidised pyrimidines and belongs to 
the HhH-GPD superfamily of DNA-glycosylases. The first EndoIII protein to be both 
functionally and structurally characterised was E. coli EndoIII. It consists of two domains 
with four N-terminal α-helices and a C-terminal six α-helix barrel. Between the two domains 
is a solvent filled groove containing the active site and in which the DNA is bound (Fromme 
and Verdine 2003). Both domains have well-conserved DNA interacting motifs, a Helix-
hairpin-Helix motif (HhH) and a [Fe4S4] cluster loop, which is unique to the HhH-GDP 
family proteins. The metal cluster is a redox-inactive cubane [4Fe-4S]-cluster coordinated in 
position by a loop with four conserved cysteines (C-X6-C-X2-C-X5-C).  
 A. Sarre is now in the process of writing-up her PhD thesis in the form of three 
manuscripts, in which she describes the crystal structures of two of the three EndoIIIs of D. 
radiodurans (EndoIII-1 and EndoIII-3) and the in vitro characterisation of the catalytic 
activity and substrate specificity of these three enzymes. Despite numerous tries, crystals of 
EndoIII-2 could not be obtained. Instead, T. Klar (post-doc) and A. Sarre respectively solved 
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the structures of intact EndoIII-1 and of an N-terminally truncated EndoIII-3 (ΔN76-EndoIII-
3), with the help of M. Ökvist (Figure 33). In both cases, the structures were solved by SAD 
method making use of the bound iron as an intrinsic anomalous scatterer. The EndoIII-1 and 
ΔN76-EndoIII-3 structures were refined respectively to 1.95 and 1.31 Å resolution (Table 10). 
In the absence of a crystal structure for EndoIII-2, a homology model was prepared using E. 
coli EndoIII as a basis for the modelling, which shares 47% sequence identity with D. 
radiodurans EndoIII-2 (Figure 33). Overall, the structures of E. coli and D. radiodurans 
EndoIIIs are very similar. However, there are a number of differences particularly in the DNA 
binding groove, where a number of active site residues and DNA binding residues differ from 
one enzyme to the other.  
 To better understand the importance of these small structural differences, A. Sarre has 
investigated the ability of the three D. radiodurans EndoIII enzymes to recognise and remove 
thymine glycol (Tg; a known substrate of EndoIII) from DNA. Interestingly, the three 
EndoIIIs are very distinct in terms of activity. Based on sequence alignments, EndoIII-2 is the 
most similar to E. coli and human EndoIII, and indeed it is also an active bifunctional enzyme 
on Tg-containing DNA (Figure 34). In contrast, EndoIII-1 only possesses DNA glycosylase 
activity on Tg-DNA and not AP-lyase activity as expected for a bifunctional glycosylase. 
EndoIII-1 is therefore only a monofunctional enzyme. Finally EndoIII-3 appears to have no 
activity on Tg-DNA. We now hope to identify additional and perhaps novel substrates for 
these three enzymes. 
 
Figure 34: Cleavage of Thymine glycol (Tg) containing DNA. A 35-mer duplex 
oligonucleotide containing a single Tg at position 14 and 5’ labelled with 6-FAM was 
incubated for 1 hour at 37ºC with either no enzyme (C), E. coli EndoIII (Ec), D. radiodurans 
EndoIII-1 (1), EndoIII-2 (2) or EndoIII-3 (3). Cleaved DNA was separated from intact DNA 
by 20% denaturing urea-PAGE and visualised on a fluorescence imager. On the right, prior 
to electrophoresis, NaOH was added to each of the samples containing enzyme, which causes 
abasic site containing DNA to be cleaved. This allows differentiating between mono- and bi-
functional activities of EndoIIIs. 
 Since 2010, I have been collaborating with Jean-François Constant and Muriel 
Jourdan from the University Joseph Fourier in Grenoble on the study of MutM (also known as 
Fpg, Formamidopyrimidine glycosylase) from D. radiodurans. A PhD student, Morgane 
Lourdin, has expressed and purified the protein and the aim of her project is to carry out 
structural (NMR and X-ray crystallography) and functional studies on this enzyme. The 
establishment of a reliable purification protocol was carried out at ESRF and since 2011 at 
IBS under my supervision. We are now trying to obtain crystals of the enzyme alone and in 
complex with abasic site containing DNA oligonucleotides. 
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Part III: Research Project 
 The prime objective for every life form is to deliver its genetic material, intact and 
unchanged, to the next generation, despite constant assaults from both endogenous and 
environmental sources on the DNA. The average human cell suffers over 10,000 DNA lesions 
per day (Ames, Shigenaga et al. 1993). If left unrepaired, damaged DNA generates mutations, 
replication errors, persistent DNA damage and genomic instability that ultimately threaten 
cell or organism viability. To counter this threat, cells have evolved several elaborate DNA 
damage response systems. The wide diversity of DNA lesions necessitates multiple, largely 
distinct DNA repair mechanisms (Jackson and Bartek 2009). Deletions/insertions and specific 
base modifications (oxidation, methylation) are repaired via the mismatch repair and BER 
pathways respectively, while UV-mediated damage is repaired via the NER pathway. In the 
case of double-strand break repair, two mechanisms are known to be involved, namely non-
homologous end-joining and homologous recombination. The principles and underlying 
mechanisms of DNA repair are largely conserved throughout evolution, though the 
complexity of the systems varies immensely. This is largely due to the requirement for a 
coordinated response to DNA damage in higher eukaryotes - a global mechanism known as 
DNA Damage Response (DDR) – a process that includes damage recognition, intracellular 
signalling via protein kinases, DNA damage repair and regulation of diverse cellular 
responses such as the cell cycle, chromatin remodelling and gene transcription (Jackson and 
Bartek 2009). 
Mutations of the genes involved in DNA repair are directly responsible for several 
human syndromes and are associated with a dramatic increase in predisposition to cancer. A 
hallmark of cancer is genome instability and most carcinogens operate by generating DNA 
damage and causing mutations (Jackson and Bartek 2009). Paradoxically, the ability of cancer 
cells to repair DNA damage after chemo- or radiotherapy significantly reduces the efficiency 
of available treatments. As a result, proteins involved in DNA repair pathways are now being 
viewed as potential drug targets. More recently, a number of viruses have been shown to 
interfere with host cellular DNA repair pathways, by either trying to evade the cellular 
response or by hijacking the cellular damage response pathway to facilitate their own 
replication. These observations suggest that the interactions of these viral proteins with the 
host DNA repair machinery constitute an attractive target for drug development. In the recent 
years, small molecule inhibitors of DNA repair proteins have successfully been used to 
potentiate the effect of radiotherapy in the treatment of several cancers and to significantly 
reduce the ability of HIV-1 to replicate in cells. At present, screening and designing specific 
inhibitors for these new drug targets are largely dependent on the availability of high-
resolution crystal structures of these essential DNA repair enzymes and a more detailed 
understanding of the molecular mechanisms underlying these processes. 
 The primary interest of my newly established team at IBS is the study of the molecular 
mechanisms underlying DNA damage recognition and repair in humans and in the radiation-
resistant bacterium Deinococcus radiodurans. Our work focuses on two major aspects, which 
are (i) Recognition of DNA Lesions and (ii) Dynamics of DNA Damage Repair Processes.  
The main objectives will be to determine the crystal structures of several DNA repair 
enzymes alone or in complex with their DNA substrates or protein partners and to study the 
dynamics of DNA damage recognition and protein assembly at sites of DNA lesion. In the 
long term, these structures will be analysed in light of known mutations in these genes 
associated with cancer predispositions and will be used to screen and design small molecule 
inhibitors that could be used to either reduce viral replication or potentiate the efficacy of 
current anti-cancer drugs. The goal is to use a combination of Structural Biology methods, 
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Biophysical and Biochemical tools and single-molecule fluorescence techniques to decipher 
the complex molecular processes leading to efficient repair of DNA lesions. 
 A. Recognition of DNA Lesions  
 DNA damage recognition is a very challenging cellular process, which consists in 
detecting very small modifications to DNA bases in a large pool of intact DNA. Ultra-violet 
(UV) light is the most pervasive environmental DNA-damaging agent and introduces a 
diversity of lesions. NER is the primary pathway for repair of such lesions and in prokaryotes, 
recent studies reveal that efficient recognition of such a broad set of lesions is largely 
accomplished by a single protein, UvrA. In contrast the BER enzymes, responsible for 
repairing lesions associated with oxidative stress, are very different in that they are multiple 
(13 DNA glycosylases in D. radiodurans) and each one of them recognises only a very small 
set of chemically related DNA lesions and hydrolyse the N-glycosidic bonds of the aberrant 
base. We would therefore like to address the following questions: how does a small set of 
NER proteins recognise a broad range of structurally diverse DNA lesions or DNA 
distortions? How do the specialised BER enzymes recognise small chemical modifications to 
bases within a large pool of undamaged DNA?  
 
Figure 35: (A) Structures of the two principal DNA lesions induced by UV light. CPD: 
cyclobutane pyrimidine dimer and (6-4) photoproduct. (B)-(C) Fluorescence anisotropy 
measurements of UvrA2 binding to intact (B) and CPD-containing (C) 30mer dsDNA 
oligonucleotides in the absence (black line) and presence of 1 mM ATP (red line). Similar 
measurements were carried out in the presence of 1 mM AMPPNP (not shown). (D) 
Dissociation constants (Kd, nM) derived from the data presented in (B) and (C). 
 To answer these questions, our initial goal will be to study the substrate specificity and 
determine the high-resolution crystal structures of D. radiodurans UvrAs and two human 
BER enzymes (hNTH1 and hMYH), associated with increased risks of cancer, in complex 
with oligonucleotides containing DNA lesions. This project will greatly benefit from our 
newly established collaboration with Jean-Luc Ravanat and Didier Gasparutto from the 
‘Lésions des Acides Nucléiques’ laboratory of the CEA in Grenoble, who are world-leaders in 
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the synthesis of lesion-containing oligonucleotides and the identification and characterisation 
of damaged DNA bases. In the long-term we will also analyse these crystal structures in view 
of known mutations in these genes associated with cancer predispositions and use them to 
design specific inhibitors that could be used to potentiate the efficacy of drugs currently used 
in chemo- or radiotherapy. 
 In the case of the NER pathway, we will initially focus on determining the substrate 
specificity of D. radiodurans UvrAs (UvrA1 and UvrA2) and the role of ATP binding and 
hydrolysis in the processes of DNA binding and damage recognition. Identifying good DNA 
substrates for these proteins will allow us to initiate crystallisation trials to obtain high 
resolution crystal structures of UvrAs in complex with damaged DNA in order to map the 
specific interactions required for damage recognition and better understand the molecular 
mechanisms involved in regulating this ATP-dependent process. Figure 35 illustrates our first 
results on the study of UvrA2 binding to intact and cyclobutane pyrimidine dimer (CPD)-
containing 30mer dsDNA oligonucleotides. The presence of a nucleotide (ATP or AMPPNP) 
increases the affinity of UvrA2 for dsDNA. UvrA2 binds with higher affinity to damaged 
DNA in the absence of nucleotide or with ATP, while the addition of non-hydrolysable ATP 
(AMPPNP) locks the protein on the DNA and blocks its ability to discriminate between intact 
and damaged DNA.  
 
Figure 36: (A) hNTH1 excision activity on γ-irradiated (75 Gy) genomic DNA. The histogram 
shows the fraction of 5-hydroxycytosine (5-OHdCyd), Thymine glycol (ThyGlycol) and 8-
oxoguanine (8-oxodGuo) excised by hNTH1 in 1 hour at 37°C. (B). Enzymatic activity of 
15nM hNTH1 on 0 to 100nM 35 base-pair (bp) oligonucleotide containing a thymine glycol 
lesion in position 14. Our data points were fitted to a standard Michaelis-Menten curve and 
estimated KM and Kcat values are shown. 
In the case of the BER pathway, our initial work has focused on the human 
Endonuclease III enzyme (hNTH1). A codon-optimised full-length construct of hNTH1 was 
expressed in E. coli and a purification protocol was established yielding milligrams of active 
enzyme. A Masters student, S. Gauthier, characterised hNTH1’s enzymatic activity on 
thymine glycol (Tg) containing dsDNA oligonucleotides in order to study the kinetics of the 
reaction (Figure 36). In collaboration with J.-L. Ravanat from the CEA, we have also 
confirmed that hNTH1 can specifically excise Tg and 5-hydroxycytosine from irradiated 
genomic DNA using liquid chromatography coupled to mass spectrometry analysis (Figure 
36). New DNA substrates are currently being synthesised in order to further investigate the 
substrate specificity of hNTH1 and identify suitable substrates for co-crystallisation.  In the 
case of bifunctional DNA glycosylases, stable protein-DNA complexes can be obtained either 
by introducing mutations into the protein to make it inactive or by making use of their ability 
to form an irreversible covalent attachment to a DNA substrate in the presence of borohydride 
ion through the reduction of the Schiff base intermediate. 
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B. Dynamics of DNA Damage Repair Processes 
In addition to our high-resolution structural work, we wish to investigate the dynamics 
of DNA repair processes and the critical protein-protein and protein-DNA interactions that 
regulate DNA damage recognition and repair in order to define more precisely the sequence 
of events leading from lesion detection to efficient repair.  
We will use single-molecule fluorescence techniques to study the dynamics of NER 
by the Uvr proteins and more particularly the early steps of NER involving damage 
recognition by UvrA and UvrB proteins. In collaboration with Dr. Virgile Adam from the IBS 
in Grenoble and Robert Neely from the University of Leuven in Belgium, we are developing a 
fluorescence-based in vitro assay in which we will study the interactions (using Förster 
resonance energy transfer, FRET) and dynamics (single-molecule imaging) of this process. A 
few months ago we also initiated experiments to look at the dynamics of the Uvr repair 
system in vivo using super-resolution microscopy (Photoactivated localisation microscopy, 
PALM). A Masters student, Rémy Flores-Flores supervised by V. Adam carried out 
preliminary experiments in E. coli to identify the best photoconvertible fluorescent proteins to 
fuse to our proteins of interest. We obtained very nice images using either Dendra2 or 
mEOSFP-M159A (Adam, Moeyaert et al. 2011) as fluorescent proteins (Figure 37). The 
localisation is very reminiscent of nucleoid staining previously seen in super-resolution 
microscopy images of the nucleoid-associated protein HU (Lee, Thompson et al. 2011) 
(Figure 37C). Experiments are now underway to introduce genes encoding these fluorescent 
proteins downstream of the two UvrA genes and the UvrB gene in D. radiodurans’ genome in 
order to follow their localisation in response to UV irradiation. The genetic modification of D. 
radiodurans is carried out in collaboration with Prof. Suzanne Sommer from Orsay. 
    
Figure 37: (A)-(B) Diffraction-limited images (top) and super-resolution images (bottom) of 
Dendra2-UvrA1 (A) and mEOSFP-M159A-UvrA1 (B) in fixed E. coli cells overexpressing 
UvrA1 in fusion with either Dendra2 or mEOSFP-M159A (Adam, Moeyaert et al. 2011). (C) 
Example of diffraction-limited (top) and super-resolution (bottom) images of the nucleoid-
associated protein HU fused to eYFP in fixed C. crescentus (Lee, Thompson et al. 2011). 
Scale bars represent 0.5µm. 
In 2011, the successful expression and purification of D. radiodurans UvrC allowed 
us to initiate interaction studies with UvrB. Unlike UvrA and UvrB, which do not form a 
stable complex in our hands, we were able to isolate a stable UvrB-UvrC complex and start to 
characterise such a complex (Figure 38). The complex seems to form in a 1:1 stoichiometry 
and, unlike the individual proteins, binds very efficiently to fluorescein-containing dsDNA. 
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Initial crystallisation trials of a ternary complex containing UvrB, UvrC and dsDNA were 
carried out and yielded some promising hits, which now need to be improved. 
 
Figure 38: (A) SEC profile of the UvrB-UvrC complex from D. radiodurans, separated on a 
Superdex 200 column. (B) SDS-PAGE analysis of the UvrB-UvrC complex. (C) Initial crystal 
hits of UvrB-UvrC-dsDNA obtained from the crystallisation robot. The crystal is mounted in 
a cryoloop and centered in the beam on the microfocus beamline at the ESRF.   
In humans, the Y-box-binding protein 1 (YB-1), which is a multifunctional 
transcription factor, has recently been shown to interact directly with hNTH1 and stimulate its 
DNA repair activity. YB-1 is directly involved in the cellular response to genotoxic stress and 
is up-regulated in tumour cell lines resistant to cisplatin (Bargou, Jurchott et al. 1997; Janz, 
Harbeck et al. 2002). The abundance of YB-1/hNTH1 complex was shown to increase in 
tumour cells treated with UV light and cisplatin and siRNA specific to hNTH1 mRNA 
increases cisplatin-sensitivity in YB-1 overexpressing cells (Guay, Garand et al. 2008). These 
findings indicate that the enzymatic activity of hNTH1 constitutes a potential drug target 
against cisplatin-resistant and perhaps also radiation-resistant tumours. In order to improve 
our understanding of the role of YB-1 and hNTH1 in the cellular response to genotoxic stress, 
we also wish to further characterise the YB-1/hNTH1 complex at both a biochemical (in 
vitro) and cellular (in vivo) level. We will carry out the biophysical characterisation of the 
complex using multi-angle laser light scattering coupled to SEC to estimate its size and 
stoichiometry, and Surface Plasmon Resonance or Isothermal Titration Calorimetry to 
estimate binding constants. We will also study the complex by SAXS to obtain low-resolution 
envelopes and will submit the purified YB-1/hNTH1 complex (or complexes of relevant 
protein domains) to the local crystallisation platform in Grenoble in order to obtain crystals 
suitable for diffraction experiments. 
Finally, we would like to further characterise the interactions and dynamics involved 
in the formation of the RecO-RecR and the RecR-RecF complexes from D. radiodurans and 
try to understand the role of DNA in this process. Since we have already determined two 
crystal structures of the RecO-RecR complex, we will focus on obtaining crystals of the 
RecR-RecF complex and will use a combination of SANS and SAXS to characterise the 
different assemblies formed in the presence of DNA. Of course, this structural work will be 
supported by biochemical and biophysical studies of these complexes in vitro so as to 
determine the stoichiometry and oligomeric states of the various subunits in the complexes. 
Our work on D. radiodurans RecN will also be continued with a focus on the characterisation 
of the full-length RecN. Our work will focus on (i) identifying the areas required for DNA 
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binding and DSB recognition, (ii) characterising its oligomeric state and ability to polymerise 
along DNA and (iii) identifying cellular binding partners of RecN.  
The long-term perspectives of this project are: 
1. Improving our understanding of the detailed mechanisms underlying DNA repair and 
recognition of DNA lesions – a very challenging process which involves finding 
small modifications to bases in a sea of undamaged DNA.  
 
2. Identification of new anti-cancer drug targets and design of specific inhibitors based 
on high-resolution crystal structures of such target enzymes. 
 
 This research project is currently supported by an ATIP-AVENIR grant from the 
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support our work on the functional characterisation of the Endonuclease III enzymes and a 
grant from the Association pour la Recherche sur le Cancer (ARC) was obtained in 2012 for 
our structural studies of DNA repair proteins in complex with lesion-containing DNA. 
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